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General introduction and scope of  the thesis
Insufficient sleep may have serious consequences for health and well-being. It has 
been suggested that short sleep may in the long run contribute to metabolic diseases 
such as obesity and type 2 diabetes. To address this issue, we experimentally 
restricted or disrupted sleep in rats under controlled laboratory conditions, which 
allowed for a detailed assessment of the metabolic consequences of sleep loss 
and its underlying mechanisms.
Sleep restriction and health
Over the past 50 years, average sleep duration in Western societies has 
decreased by almost 2 hours per night (Figure 1). This may not be without 
consequences. A decrease in the length and quality of sleep has been identified 
as a risk factor for the development of various diseases, such as mood disorders 
(Breslau et al., 1996;Ford and Kamerow, 1989;Neckelmann et al., 2007), immune 
system dysfunction (Imeri and Opp, 2009;Irwin, 2002;Opp and Toth, 2003) and 
cardiovascular disorders (Gangwisch, 2009;Knutson, 2010;Mullington et al., 
2009).
Along these same lines, many epidemiological studies in the last decade have 
shown correlations between short sleep and increased prevalence of metabolic 
disorders such as obesity and type 2 diabetes, in both adults and children (Chaput 
et al., 2006;Horne, 2011;Van Cauter and Knutson, 2008). In addition, decreased 
sleep quality has been linked to metabolic disorders. One typical example 
of reduced sleep quality in our modern society is shift work. Shift workers are 
expected to sleep at times when their biological clock is competing to maintain 
wakefulness. Hence, shift work is often associated with disturbed sleep (Akerstedt, 
2003). Several studies have shown that shift work constitutes a risk factor for 
Figure 1: Self-reported sleep duration (adapted from (Van Cauter et al., 2005)) and the percentage of obese 




obesity and type 2 diabetes (Akerstedt, 2003;Antunes et al., 2010;Atkinson et 
al., 2008;Knutsson, 2003;van Amelsvoort et al., 1999), providing support for the 
suggested link between reduced sleep quality and metabolic disorders.
 Another example for a relation between decreased sleep quality and metabolic 
disorders comes from people who suffer from obstructive sleep apnea (OSA), 
which is characterized by airway collapses during sleep, causing brief but 
frequent awakenings to resume breathing (Bandla and Gozal, 2000;Svanborg 
and Guilleminault, 1996). These frequent awakenings result in a serious reduction 
in sleep quality, even though the overall amount of sleep is not dramatically 
decreased. Vgontzas and colleagues reported a positive correlation between 
OSA and the development of obesity, type 2 diabetes and cardiovascular disease 
(Vgontzas et al., 2003). In fact, the relationship between OSA and obesity seems 
to be bidirectional: sleep apnea leads to obesity and weight gain also negatively 
impacts breathing and may lead to poor sleep quality (Peppard et al., 2000;Pillar 
and Shehadeh, 2008). 
 Although epidemiological and clinical studies report a clear association 
between restricted or disrupted sleep and metabolic disorders, it is unclear 
whether the relationship is causal. A causal relationship can only be established 
by experimental studies. Understandably, no study in humans has ever applied 
chronic sleep disturbance to the point that it resulted in diabetes type 2 or obesity. 
However, there are several experimental studies that assessed more immediate 
effects of sleep deprivation or restriction on metabolic processes that contribute to 
our understanding of this relationship.
Sleep restriction and metabolism in humans
Different approaches and terms have been used in literature to study sleep 
loss. Many studies in both humans and rodents have focused on the negative 
consequences of total sleep deprivation, which indicates that the subjects 
were not allowed to sleep at all for a certain period of time. However, chronic 
sleep restriction or disruption is a more common problem. Sleep restriction is 
characterized by shortening the amount of sleep per night, whereas sleep 
disturbance is characterized by arousals occurring throughout the night, without 
severely reducing the total amount of time spent asleep. 
 One of the first experimental studies that provided evidence for a direct effect of 
sleep restriction on glucose homeostasis was performed by Spiegel and colleagues 
in 1999 (Spiegel et al., 1999). Healthy subjects were exposed to 5 nights of 
restricted sleep, with 4h of sleep per night, and then subjected to an intravenous 
glucose tolerance test (IVGTT). An IVGTT is used to evaluate insulin response 
and glucose clearance after glucose infusion. It has been shown previously 
that an IVGTT is a successful tool to study glucose homeostasis (Strubbe and 
Bouman, 1978). Sleep restricted subjects displayed a decreased insulin response 
and an attenuated clearance of glucose from the blood in response to an IVGTT. 
The authors interpreted these results as a decrease in glucose tolerance (i.e., 
glucose intolerance) and concluded that sleep restriction has a harmful impact 
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on metabolism. It was suggested that the sleep restriction-induced decrease in 
glucose tolerance might reflect a first step towards the development of type 2 
diabetes. A follow-up study showed that several consecutive nights of reduced 
deep sleep without changes in total sleep time resulted in reduced insulin sensitivity 
and glucose intolerance (Tasali et al., 2008). A more recent study demonstrated 
that only one night of sleep restriction (4h of sleep allowance) is sufficient to cause 
moderate insulin resistance as measured by a hyperinsulineamic euglycemic 
clamp (Donga et al. 2010). 
 Regulatory hormones such as the orexigenic hormone ghrelin and the adiposity 
modulators leptin and insulin have a clear influence on food intake, fat mass, 
and body weight (review: Spiegelman and Flier, 2001). For that reason, several 
studies have assessed the effects of sleep restriction on feelings of hunger as well 
as on these regulatory hormones. A few days of sleep restriction lead to increased 
feelings of hunger accompanied by a decrease in leptin and an increase in ghrelin 
(Spiegel et al., 2004a;Spiegel et al., 2004b;Taheri et al., 2004). In contrast, another 
study with a similar degree of sleep restriction failed to reproduce these results, 
showing increased concentrations of leptin with no changes in feelings of hunger 
(van Leeuwen et al., 2010). The reason for this inconsistency is unclear, but it 
might be explained by differences in the length of the sleep restriction period, the 
amount of activity allowed and/or differences in energy intake. 
 The finding that sleep restriction has direct effects on glucose tolerance, 
insulin sensitivity and feelings of hunger is in agreement with epidemiological 
data suggesting that sleep restriction may serve as a risk factor for developing 
obesity and type 2 diabetes. However, it is not known how persistent the metabolic 
changes in these experimental studies are. It is important to investigate whether 
these metabolic changes would really lead to metabolic dysfunction in the long 
run, in case restricted sleep would truly become a chronic condition. Experimental 
studies in animals are of importance here. Animal models allow us to investigate 
the underlying mechanisms of sleep restriction induced changes in metabolic 
regulation both during acute and prolonged sleep restriction.
Sleep restriction and metabolism in rats
Experimental studies in rats have shown that sleep restriction leads to changes 
in food intake, body weight and regulating hormones such as insulin and leptin. 
In almost all studies, sleep deprivation led to an attenuation of weight gain, often 
associated with increased food intake (Everson and Crowley, 2004;Hipolide et 
al., 2006;Koban and Stewart, 2006;Koban et al., 2008). In rats, the adiposity 
modulators leptin (Everson and Crowley, 2004;Koban and Swinson, 2005) and 
insulin (Hipolide et al., 2006) generally decrease during sleep deprivation, which 
may be secondary to the attenuation of weight gain. Acute sleep deprivation 
does not affect body weight and leptin concentrations, but it does increase the 
concentration of the hunger hormone ghrelin (Bodosi et al., 2004). 
 While results from experimental rat studies are relatively consistent, the 




in basal concentrations of insulin provide little information regarding insulin 
responses and glucose regulation under challenging conditions, i.e., in response 
to food intake. Additionally, none of these animal studies assessed glucose 
homeostasis by means of an IVGTT or a hyperinsulineamic euglycemic clamp. Also, 
while changes in metabolic hormones in animal studies appear to be consistent 
with data from human studies, the reduction in body weight found in rats has not 
been reported in humans. In fact, this finding is in contrast to the proposed role 
of short sleep in obesity as based on epidemiological studies. One should realize 
that the data on sleep restriction and metabolism in laboratory animals are derived 
from a wide variety of sleep restriction protocols, from short and prolonged total 
sleep deprivation to selective REM sleep deprivation. Unfortunately, few studies 
so far assessed the metabolic consequences of chronic partial sleep deprivation 
or sleep disturbance as it often occurs in our society, which is therefore the specific 
aim of the current project. 
Sleep restriction methods for rat studies
As mentioned before, there is a wide variety of methods available for sleep 
deprivation in animals, each of which may have its own specific effects and 
confounding factors (Rechtschaffen et al., 1999). Not all of these methods are 
suitable for studies on chronic sleep restriction and metabolism. A commonly used 
method for acute sleep deprivation is the gentle handling method. When used in 
our lab, animals are kept awake by a protocol consisting of tapping on the cage, 
gently shaking the cage and, if necessary, disturbing the nest (Hagewoud et al., 
2010;Van der Borght et al., 2006). While this method is relatively mild and appears 
to produce little stress in the animals, it is only practical for sleep deprivation 
of short duration because it requires a direct and continuous involvement of the 
experimenter. For chronic purposes, the following methods are available. 
 The flower pot method or platform method is known for its ability to selectively 
deprive rats of rapid-eye-movement (REM) sleep for prolonged periods of time 
(Cohen and Dement, 1965;Mendelson et al., 1974). The method is based on the 
fact that REM sleep is characterized by a complete loss of muscle tone. Rats are 
placed on a small platform or upside-down flower pot, surrounded by water. As 
soon as the rat enters the REM sleep stage and loses muscle tone, it will touch or 
fall into the water and wake up. The movement restriction and risk of falling into 
the water makes this method rather stressful and may have immediate and non-
specific effects on metabolism that could confound the result of our experiments.  
 Another method is the disk-over-water method, which is described by 
Rechtschaffen and colleagues (Rechtschaffen and Bergmann, 1995;Rechtschaffen 
and Bergmann, 2002). This method is based on continuous recording and online 
analysis of brain activity (electroencephalogram, EEG) and neck muscle activity 
(electromyogram, EMG). Rats are housed on a horizontal disk above water. As 
soon as the EEG and EMG signals indicate the onset of sleep, the disk starts to 
rotate at a low speed which awakens the rat and forces it to walk to avoid being 
carried into the water. This method has proven to be highly effective for prolonged 
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sleep deprivation studies but requires a computer-driven sleep deprivation set up 
for each individual rat. It also has the disadvantage that all rats in each experiment 
need to be equipped with electrodes for recording EEG and EMG. Moreover, the 
risk of rats eventually falling in the water is again not preferable in the context of 
studies on sleep restriction and metabolism.
 A slightly different but simpler method is the rotating drum method, which is also 
based on forced locomotion. This method was originally described by Borbely and 
colleagues (Borbely and Neuhauss, 1979;Borbely et al., 1984). With this method, 
rodents are kept awake by placing them in a slowly and continuously rotating 
drum. In our lab, the rotating drum method has been used extensively for studies 
in rats that were aimed at mimicking restricted sleep as it often occurs in our 
society. In these studies, rats are generally allowed 4h of sleep per day. During 
the remaining 20h, rats are placed in the rotating drums and are forced to maintain 
wakefulness. To control for the mild forced locomotion in this sleep restriction 
protocol, another group of rats is subjected to forced locomotion for 10 h in the 
drum rotating at double the speed of the experimental group. With this protocol, 
rats walk the same distance as sleep restricted rats, but have sufficient time to 
sleep (14h). This approach has previously been validated in the context of mood 
disorders. In a series of studies, it was shown that chronically restricted sleep 
leads to neurobiological and neuroendocrine changes that are similar to what 
has been reported for depressed patients, e.g., reduced serotonin 1A receptor 
sensitivity (Novati et al., 2008;Roman et al., 2005), altered hypothalamic-pituitary-
adrenal axis regulation (Novati et al., 2008), and reduced hippocampal volume 
(Novati et al., 2011). Some of these changes did not occur after acute, short sleep 
deprivation but only developed gradually in the course of a prolonged period of 
sleep restriction (Novati et al., 2008;Roman et al., 2005). Moreover, some of the 
changes, such as the decrease in serotonin (5-HT) 1A sensitivity, proved to be 
rather long-lasting. Together these findings indicate that chronically restricted 
sleep may induce gradually developing and long-lasting consequences that have 
suggested implications for disease sensitivity. Therefore, sleep restriction induced 
by the rotating drum may serve as an appropriate approach for studies on the 
metabolic consequences of sleep loss as well.
Aim and scope of the thesis
Taken together, the data from experimental studies in humans and rodents do not 
yet provide a complete picture on the consequences of chronic sleep restriction for 
metabolic regulation.  Moreover, most rat studies are based on acute or prolonged 
total sleep deprivation or on selective REM sleep deprivation. Few studies 
assessed the consequences of chronic partial sleep deprivation as it often occurs 
in our modern society. Therefore, the aim of this thesis is to provide a detailed 
assessment of metabolic regulation in rats under conditions of both acute and 
chronic sleep restriction.
 In Chapter 2 we investigated the effects of chronic sleep restriction on sleep-




and insulin. Since sleep deprived or sleep restricted rats commonly show weight 
loss or attenuated weight gain despite an increase in food intake, we measured 
whether this attenuated weight gain might be the consequence of increased 
energy expenditure. Energy expenditure was measured during sleep restriction by 
means of the doubly labeled water method. 
 Although it is known that sleep deprivation may cause a decrease in basal 
concentrations of insulin, the interpretation of this result in terms of glucose 
regulation is met with difficulty. Changes in basal concentrations of insulin do 
not provide a clear picture of insulin responses and glucoses homeostasis under 
challenging conditions such as food intake. In chapter 3 we investigated if chronic 
sleep restriction affects insulin responses and glucose homeostasis by means of a 
controlled IVGTT. 
 Since our rotating drum method for sleep deprivation involves forced locomotion, 
we performed an experiment to study whether metabolic changes following chronic 
sleep restriction might be mediated by increased activity or by sleep loss per 
se. We therefore investigated the effect of forced and voluntary running activity 
on insulin regulation and glucose homeostasis by means of an IVGTT, without 
disturbing the sleep-wake pattern or total sleep time (chapter 4). 
 We then asked the question whether metabolic changes following chronic sleep 
restriction are due to a critical reduction in sleep duration or due to disruption of 
the sleep-wake rhythm, i.e., a circadian disruption irrespective of sleep time. For 
that reason we assessed the effects of a shift work protocol by forcing rats to be 
active during their normal resting phase without restricting their sleep time and 
measured the effects on insulin regulation and glucose homeostasis (chapter 5). 
 The attenuation of weight gain in sleep deprived or sleep restricted rats is 
in conflict with the hypothesis that sleep loss may lead to obesity according to 
epidemiological correlations. This apparent difference with the human situation 
may be caused by the alternation between periods of sleep restriction and sleep 
allowance that often occur in real life. Therefore, in chapter 6 we studied the 
metabolic consequences of a chronic sleep restriction protocol that modeled 
working weeks with restricted sleep time alternated with weekends of sleep 
allowance. We hypothesized that these weekends might not only allow the rats to 
recover from a weight deficit but that it could even lead to an overall weight gain.
 Another explanation for this apparent difference in weight gain between 
rats and the human situation may be a difference in diet. Therefore we assessed 
in chapter 7 the effects of a medium fat diet versus a standard chow diet during 
chronic sleep restriction on body weight, food intake and regulatory hormones such 
as leptin and insulin. In addition we studied the effects of both diets during sleep 
restriction on the serotonergic system in order to evaluate a potential connection 
with previous experiments performed in our laboratory, which demonstrated that 
chronic sleep restriction leads to reduced serotonin 1A receptor sensitivity. We 
hypothesized that metabolic consequences of sleep restriction underlie these 
neurobiological changes. Thus, a medium fat diet may, at least partially, prevent 
the attenuation of weight gain seen during sleep restriction and protect against the 
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desensitization of the serotonin 1A receptor seen previously after chronic sleep 
restriction. 
 Chapter 8 summarizes and discusses the main outcomes of our sleep restriction 
on glucose homeostasis data and how it relates to the literature, whereas chapter 9
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Epidemiological studies have shown an association between short or disrupted 
sleep and an increased risk to develop obesity. In animal studies, however, sleep 
restriction leads to an attenuation of weight gain that cannot be explained by 
changes in energy intake. In the present study, we assessed whether the attenuated 
weight gain under conditions of restricted sleep is a consequence of an overall 
increase in energy expenditure. Adult male rats were subjected to a schedule 
of chronic sleep restriction (SR) for 8 days with a 4h window of unrestricted rest 
per day. Electroencephalogram and electromyogram recordings were performed 
to quantify the effect of the sleep restriction schedule on sleep-wake patterns. 
In a separate experiment, we measured sleep restriction-induced changes in 
body weight, food intake, and regulatory hormones such as glucose, insulin, 
leptin and corticosterone. To investigate whether a change in energy expenditure 
underlies the attenuation of weight gain, energy expenditure was measured by 
the doubly labeled water method from day 5 until day 8 of the SR protocol. 
Results show a clear attenuation of weight gain during sleep restriction but 
no change in food intake. Basal plasma glucose, insulin and leptin levels are 
decreased after sleep restriction which presumably reflects the nutritional status 
of the rats. The daily energy expenditure during SR was significantly increased 
compared to control rats. Together, we conclude that the attenuation of body 
weight gain in sleep restricted rats is explained by an overall increase in energy 
expenditure together with an unaltered energy intake.
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Metabolic consequences of  chronic sleep restriction in rats: changes in body weight regulation 
and energy expenditure
Introduction
A substantial number of studies have demonstrated a correlation between short 
sleep and increased prevalence of obesity ((Bjorvatn et al., 2007;Chaput et al., 
2006;Chaput et al., 2009;Gangwisch et al., 2005;Hasler et al., 2004), for an overview 
see (Cappuccio et al., 2008)). While these studies form an important basis for the 
hypothesis that restricted sleep may contribute to metabolic diseases, they do not 
provide information on the cause and consequence in this relationship (Cizza et 
al., 2005;Marshall et al., 2008). To determine the relationship between insufficient 
sleep and altered metabolic regulation, controlled studies with experimental sleep 
restriction are required. 
 The present study aimed to assess the effects of chronic sleep restriction 
on energy metabolism in rats. For this purpose, we used a well-established 
rotating drum system to keep rats awake. Previously, we reported that chronic 
sleep restriction induced by this rotating drum method leads to gradual and, 
in some cases, persistent changes in a variety of neurobiological systems (e.g., 
serotonergic signaling:(Roman et al., 2005;Roman et al., 2006)), neuroendocrine 
regulation (e.g., hypothalamus-pituitary-adrenal (HPA-) axis regulation: (Meerlo 
et al., 2002;Novati et al., 2008)), and physiological processes (e.g., glucose 
homeostasis: (Barf et al., 2010)). We now investigated the effect of sleep 
restriction on specific metabolic parameters, including body weight, food intake 
and circulating regulatory hormones, in particular insulin, leptin and corticosterone. 
Leptin and insulin are known adiposity signals that regulate both food intake and 
body weight (for reviews see: Woods and Seeley, 2000;Woods and D’Alessio, 
2008). Corticosterone levels reflect HPA-axis activity, which may alter metabolic 
function and regulation of metabolic hormones, as seen during stress (for reviews 
see: Pecoraro et al., 2006;Sapolsky et al., 2000). 
 We particularly focused on changes in energy expenditure during sleep 
restriction. It has been shown that experimentally disturbed sleep in rats leads 
to an attenuation of weight gain, despite normal (Barf et al., 2010) or increased 
food intake (Everson and Crowley, 2004;Hipolide et al., 2006;Koban and Stewart, 
2006;Koban et al., 2008;Rechtschaffen and Bergmann, 1995;Rechtschaffen and 
Bergmann, 2002). An increase in energy expenditure might explain this, since 
being awake and active costs more energy than being asleep (Brebbia and 
Altshuler, 1965;Ryan et al., 1989). Spending a larger part of the day awake may 
therefore increase overall energy expenditure.
 To assess the effects of sleep restriction on different aspects of energy balance, 
we exposed male rats to sleep restriction for 8 days. Body weight and food intake 
were measured daily and at the end of the sleep restriction protocol and after a 
recovery period of 5 days blood samples were taken to determine blood glucose 
and plasma insulin, leptin and corticosterone levels. Energy expenditure during 
sleep restriction was studied by the doubly labeled water method. To quantify 
the effect of sleep restriction on sleep-wake patterns, measurements of sleep 






All experiments were performed in adult male Wistar rats (Harlan Netherlands BV, 
Horst, The Netherlands) weighing approximately 320 g at the start of the experiment. 
The rats were individually housed in Plexiglas cages in a climate-controlled room 
(21 °C ± 1) under a 12:12 h light-dark cycle (lights on at 10:00 am). Rats had 
unrestricted access to water and were maintained ad lib on medium fat food
(45 % fat diet; Arie Blok Diervoeding B.V., Woerden, The Netherlands). Food intake 
and body weights were measured daily. Experiments were approved by the 
Institutional Animal Care and Use Committee of the University of Groningen.
Chronic sleep restriction
Rats were subjected to chronic sleep restriction (SR) according to a previously 
published method (Meerlo et al., 2002). The rats were allowed to sleep in their 
home cage for 4 hours per day at the beginning of the light phase, i.e., their 
normal resting phase. During the remaining 20 hours, they were kept awake 
by placing them in drums rotating at a constant speed of 0.4 m/min (Barf et al., 
2010;Novati et al., 2008;Roman et al., 2005). Rats were subjected to this schedule 
of sleep restriction for 8 days during which they had unlimited access to food and 
water inside the drums. All rats were habituated to the experimental conditions 
by placing them in the drums for 1-2 hours on 3 consecutive days before the onset of 
the sleep restriction protocol. Control rats (Control) were housed in the same room 
but were left undisturbed in their home cage throughout the experiment. During 
the recovery period afterwards, all rats were left undisturbed in their home cage. 
Experiment 1: Sleep-wake patterns and sleep EEG
In experiment 1, we assessed the actual sleep loss during the chronic sleep 
restriction protocol by measuring sleep-wake patterns and sleep EEG. To be able 
to record EEG and EMG inside the rotating drums, we used a wireless datalogger 
system mounted on the head of the animals (NeuroLogger mobile system, TSE, 
Homburg, Germany).
 The NeuroLogger head plug with electrodes for recordings of EEG and EMG 
was fixed to the skull under general isoflurane anesthesia (2%). Holes were drilled 
in the skull and 3 brass screws served as electrodes for epidural EEG (one 2.0 
mm lateral of sutura sagittalis, 1.5 mm rostral of lambda and one 2.0 mm rostral of 
the measurement electrode on the right side) and a reference electrode (2.0 mm 
mediocaudal of lambda). For placement of EMG electrodes, the neck muscle was 
pierced twice with a 21-gauge needle, approximately 2mm apart. Electrodes were 
then guided through these perforations and fixed into place using non-absorbable 
wire. Afterwards electrodes and head plug were covered with a layer of dental 
cement. A “dummy”, in size and weight comparable to the NeuroLogger, was 
attached to the head holder. After recovery from anesthesia the rat was placed 
back in its home cage. For postoperative care, rats received a single subcutaneous 
injection of finadyne (1.0 mg/kg). Rats were allowed to recover for at least 10 days 
before the start of the experiments.
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 Specialized software (CommSW, Newbehavior, Zurich, Switserland) was used 
to configure and start the NeuroLogger. EEG and EMG signals were sampled 
at 200 Hz and directly stored on a built-in 512mb data storage. The data was 
first saved in a hexadecimal format. These files were then transformed to text 
files using a MatLab routine and were further analyzed using SleepSign® for 
animals (KISSEI COMTEC, Nagano, Japan). At first, an automatic scoring took 
place using the wave form recognition and logic setup algorithm of the screening 
module of SleepSign®. Each file and epoch was then checked visually, and if 
necessary, corrected by an experienced observer. On the basis of this scoring, 
time spent in each vigilance state was calculated. In addition, the signals were 
subjected to spectral analysis by Fast Fourier Transformation (SleepSign®).
For all NREM sleep epochs, the EEG power in the 1-4 Hz delta range was calculated 
as an indicator of sleep intensity. To correct for inter-individual differences in 
strength of the EEG signal, the delta power values were normalized by expressing 
them as a percentage of each rats’ own average 24 hour baseline delta power. 
The normalized EEG delta power is referred to as slow wave activity (SWA).
 In this study, EEG and EMG measurements were done for baseline and day 1 of 
sleep restriction as well as day 8 of sleep restriction and the first day of recovery. 
In this experiment, sleep restricted rats (SR: n=4) served as their own controls.
Experiment 2: Plasma hormone levels
Experiment 2 established the effects of chronic sleep restriction on body weight, 
food intake and baseline circulating levels of blood glucose and plasma insulin, 
leptin and corticosterone. All rats in this experiment were equipped with a chronic 
jugular vein catheter allowing repeated and stress free blood sampling according 
to a previously described method (Steffens, 1969). Under 2% isoflurane inhalation 
anesthesia, a silicon heart catheter (0.95 mm OD, 0.50 mm ID) was inserted into 
the right jugular vein and kept in place with a ligament. The other end of the 
catheter was subcutaneously directed to the top of the head where it was fixed 
with dental cement and could be used to connect the rats to sampling tubes. 
Rats were allowed to recover for at least 10 days before the start of the 
experiment. Rats were then divided over two groups: a sleep restricted group 
(SR: n=11) and a home cage control group (Control: n=7). SR rats spent the first 
4h of the light phase in their regular home cages, where after they were transferred 
to the rotating drums. Blood samples were taken after 8 days of SR/Control 
(8d experiment) and after 5 days of recovery (5d recovery) during the fourth 
hour of the light period (ZT 4), at the end of the daily 4h sleep window. In case 
of blood sampling, food was removed at ZT0. 
 Blood samples (500 μL) were collected in tubes with EDTA (20 μL/ml blood) 
on ice. About 50 μL of fresh blood was immediately stored at − 20 °C for later 
determination of blood glucose levels by Hoffman’s ferrocyanide method. 
The remaining blood was centrifuged at 2600 g for 10 min and the plasma 
was then stored at − 20 °C until further analysis. Plasma levels of insulin 
were measured by Millipore Rat Insulin Radioimmunoassay (Linco Research, 




leptin Radioimmunoassay (Linco Research), and plasma levels of corticosterone 
were measured by ImmuChem 125I Corticosterone Radioimmunoassay 
(MP Biomedicals, Orangeburg, NY, USA).
Experiment 3: Energy balance
Experiment 3 aimed to assess energy expenditure during chronic sleep restriction. 
Rats were divided over 2 groups: sleep restriction (SR: n=8) and home cage controls 
(Control: n=8). Body weight and food intake (45% fat diet: 1g = 4.8 kCal) were 
measured daily. Measurement of energy expenditure during sleep restriction was 
achieved by the doubly labeled water method as described previously (Speakman, 
1998). Energy expenditure was measured over a 3-day period, from day 5 until 
day 8 of the sleep restriction protocol. In brief, at day 5 of the sleep restriction 
protocol, an intraperitoneal injection of a mixture of 2H2
16O (mixture enrichment 
of 2H = 33.32% atom%) and 1H2
18O (mixture enrichment of 18O = 65.62 atom%) 
was administered. The syringes containing the mixture were weighed to 0.1 mg 
before and after injection to obtain a dose mass. Following isotope injection rats 
returned to their home cage to allow isotope equilibration with the rat’s water pool. 
Two-and-a-half hour after injection an initial blood sample was drawn from the tail 
(Fluttert et al., 2000;Meerlo et al., 2002). At day 8 of the sleep restriction protocol, 
a second blood sample was taken at the same circadian time as the first blood 
sample. All samples were collected in 50 μl Vitrex pre-calibrated capillaries and 
were immediately flame-sealed and stored until analysis. Analysis of the blood 
samples was achieved by previously described methods (Speakman, 1998). 
Data analysis 
In experiment 1, we measured time spent in NREM sleep, REM sleep or Wake 
and NREM sleep EEG SWA during a baseline day, day 1 of SR, day 8 of SR 
and the first day of recovery. All parameters were compared to baseline by a 
Paired t-test. In experiment 2, body weight and food intake was measured daily 
during the sleep restriction protocol and recovery period afterwards. At day 8 
of SR, regulatory metabolic hormones were measured. To test the effect of 8 
days of sleep restriction and the effect of 5 days of recovery thereafter on body 
weight, data were subjected to analysis of variance (ANOVA) with repeated 
measures. To test for effects of sleep restriction on food intake and glucose, 
insulin, leptin and corticosterone levels, data were subjected to One Way 
ANOVA. In experiment 3, body weight and food intake were measured daily. 
Energy expenditure was measured by doubly labeled water during day 5 until 
day 8 of the experimental protocol. Energy balance was calculated by subtracting 
energy expenditure from energy intake. To test for effects of sleep restriction 
on delta body weight, data were subjected to repeated measures ANOVA. 
To test for the effects of sleep restriction on food intake, energy expenditure 
and energy balance, data were subjected to One Way ANOVA. For all three 
experiments, data in text and figures are expressed as averages ± SEM and 
P<0.05 was considered statistically significant.
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Figure 1: Average sleep-wake patterns under baseline conditions, during day 1 and day 8 of the sleep 
restriction protocol and on the first recovery day. Rats (n=4) were subjected to sleep deprivation (SD) for 
20 h per day. The horizontal black-and-white bar at the bottom of the panels represent the light-dark cycle.
Figure 2: The total time spent asleep or awake during the baseline day, during day 1 and day 8 of SR protocol, 
and on the first recovery day. Time spent asleep is divided into NREM and REM sleep. Data are average 
values ± SEM (n=4). Statistics is done on total sleep time and total wake time. Asterisks indicate a significant 





Experiment 1: Sleep-wake patterns and sleep EEG
The average sleep-wake pattern is shown in Figure 1 for baseline, day 1 and day 
8 of sleep restriction and the first day of recovery. The sleep restriction protocol 
reduced sleep time and increased overall waking time compared to baseline, both 
on the first and eighth day of the experiment (paired t-test: total sleep time day 
1 SR: t=16.27, P<0.01; total sleep time day 8 SR: t=18.11, P<0.01; total wake 
time day 1 SR: t= -26.97, P<0.001; total wake time day 8 SR: t= -72.59, P<0.001; 
see Figure 2 and Table 1). NREM and REM sleep time were significantly decreased 
during first and eighth day of sleep restriction (total NREM sleep day 1 SR: 
t= 25.69, P<0.001; total NREM sleep day 8 SR: t= 34.42, P<0.01; total REM 
sleep day 1 SR: t= 15.94, p<0.01; total REM sleep day 8 SR: t= 11.85, P<0.01; 
see Table 1).
 Although the sleep restriction procedure reduced NREM and REM sleep time, 
rats did have occasional micro sleeps in the rotating drum, which added up to 
approximately 1 hour of sleep during the daily 20h sleep deprivation phase, both 
on the first and eighth day of the experimental protocol (Table 1). Most of the 
sleep in the rotating drum consisted of NREM sleep, although sporadic REM 
sleep epochs occurred as well. In fact, the amount of REM sleep in the rotating 
drum significantly increased from day 1 to day 8 of the sleep restriction protocol 
(t= -7.65, P<0.05).
Baseline Day 1 Day 8 Recovery
NREM (min)
20h SR 411.8 ± 4.7 65.8 ± 9.9* 65.1 ± 13.6* 473.0 ± 9.2*
4h recovery 132.8 ± 12.1 142.1 ± 4.1 131.5 ± 3.7 130.8 ± 11.3
24h total 544.7 ± 16.7 207.9 ± 9.0* 196.6 ±17.3* 603.8 ±11.3
REM (min)
20h SR 99.5 ± 6.9 2.1 ± 1.0* 9.2 ± 1.6*# 162.3 ± 12.0*
4h recovery 26.7 ± 3.8 60.2 ± 3.1* 65.7 ± 6.8* 39.1 ± 2.2
24h total 126.2 ± 10.2 62.4 ± 3.4* 74.9 ± 8.2* 201.4 ± 12.0*
Wake (min)
20h SR 688.6 ± 10.3 1132.1 ± 9.9* 1125.7 ± 15.1* 564.7 ± 18.6*
4h recovery 80.5 ± 15.5 37.6 ± 6.7* 42.8 ± 10.4 70.1 ± 1.1
24h total 769.1 ± 25.3 1169.8 ± 7.4* 1168.8 ± 19.3* 634.8 ± 19.3*
Time spent in various sleep stages during the total 24h, 20h of sleep restriction and 4h window of sleep 
allowance (recovery) during day 1 and 8 of SR. The same time points were used for the baseline and the 
first recovery day. Data are average ± SEM. * P<0.05 compared to baseline, # P<0.01 compared to day1.
Table 1: Time (minutes) spent in NREM, REM or Wake.
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During the daily 4 hour sleep window, REM sleep time was significantly increased 
as compared to the same period under baseline conditions (day 1 SR: t= -20.96, 
P<0.001; day 8 SR: t= -10.73, P<0.01). NREM sleep time during this 4 hour 
window was not significantly changed compared to baseline conditions. However, 
the average NREM sleep EEG SWA during this 4h window was higher on sleep 
restriction days than during baseline. Due to the small sample size and variation, 
this did not reach statistical significance (SWA Baseline: 116.7 ± 1.1%, SWA Day 1 
SR: 132.5 ± 5.1%, SWA Day 8 SR: 129.0 ± 10.2%: Paired t-test: Baseline vs. Day 
1 SR: t= -3.06, P=0.055, Baseline vs. Day 8 SR: t= -1.17, P=0.36). 
 During the first day of recovery total sleep time was significantly increased 
(t=-4.99, P<0.05) and total wake time significantly decreased when compared 
to baseline (t= 5.00, P<0.05). Total REM sleep time was significantly increased 
(t=-29.13, P<0.01), but NREM sleep time was only increased during 20 h 
(t=-12.32, P<0.05) and not during total 24 h of recovery.
Experiment 2: Plasma hormone levels
Sleep restriction by forced locomotion significantly suppressed the weight gain 
that was seen in home cage control rats (Repeated Measures ANOVA: time x 
treatment interaction: F(18,306)=17.38, P<0.001; see Figure 3A). Upon termination 
of the sleep restriction protocol, weight gain seemed to normalize, but the overall 
increase in body weight remained significantly lower compared to controls even 
after 5 days of recovery. There were no significant differences in total food intake 
(Figure 3B). 
 The changes in blood glucose and plasma insulin, leptin and corticosterone 
levels after 8 days of sleep restriction and after a subsequent 5 day recovery period 
are shown in Figure 4. Blood glucose levels were significantly decreased after 8 
days of SR (One way ANOVA: F(1,14)=8.16, P<0.05) but levels had returned to 
control levels after 5 days of recovery (One way ANOVA F(1,10)=0.88, P>0.5). 
 Insulin levels were decreased after 8 days of SR compared to controls 
(One way ANOVA: F(1,14)=17.42, P<0.01) and after 5 days of recovery they were 
no longer significant different compared to controls (One way ANOVA: F(1,9)=1.30, 
P>0.1). Plasma levels of leptin showed the same pattern. After 8 days of SR, 
leptin levels were significantly decreased compared to control rats (One way 
ANOVA: F(1,12)=11.63, P<0.01) and after 5 days of recovery they were no longer 
significant different compared to controls (One way ANOVA: F(1,12)=0.71, P>0.1). 
Corticosterone levels after 8 days of SR and 5 days of recovery did not differ 
between groups. 
Experiment 3: Energy balance
Energy expenditure in SR rats, assessed by the doubly labeled water method from 
day 5 until day 8 of the sleep restriction protocol, was significantly higher compared 
to energy expenditure in home cage control rats (F(1,14)= 118.0, P<0.0001; see 
Figure 5). During the same 3-day period, food intake was not different between 




minus energy expenditure: Control: 18.8 ± 2.5 kCal/day; SR: 0.1 ± 2.2 kCal/day: 
One Way ANOVA: F(1,14)= 30.7, P<0.001). In agreement with this, weight gain 
during this 3-day period was significantly lower in sleep restricted rats than control 
animals (F(1,14)= 58.1, P<0.0001; see Figure 5). Body weight over the 3-day 
period was significantly increased over time for control rats (Repeated Measures 
ANOVA: F(1,7)= 63.57, P<0.001) and significantly decreased over time for SR rats 
(F(1,7)= 13.32, P<0.01).
Figure 3: Daily body weight (A) and food intake (B) during the baseline, experimental and recovery phase of 
the experiment for sleep restricted rats (SR, n=11) and control rats (Control, n=7). The horizontal grey bar at 
the bottom of panel A represents the 8 day sleep restriction period. Data are average values ± SEM. Asterisks 
indicate a significant difference between SR and control rats (* P<0.01).
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Figure 5: Daily energy expenditure and energy intake measured during the last 3 days of the 8-day sleep 
restriction protocol (left panel) and the change in body weight during the same 3d-period (right panel). 
Measurement of energy expenditure was performed by the doubly labeled water method and energy intake 
was calculated on the basis of food intake and the caloric value of the diet. n=8 for both groups. Data are 
average values ± SEM. Asterisks indicate a significant difference (* P<0.05).
Figure 4: Plasma levels of glucose, insulin, corticosterone and leptin at the end of the 8d experiment and after 
5d of recovery in sleep restricted rats (SR, n=11) and control rats (Control, n=7). Data are average values ± 





The slowly rotating drum method effectively restricted sleep time in rats. 
The reduction of total sleep time led to an attenuation of weight gain. During 
the sleep restriction period, energy intake in terms of food consumption was not 
affected while daily energy expenditure was significantly increased. This implies 
that the attenuation in weight gain during sleep restriction is caused by an increase 
in energy expenditure. Plasma levels of glucose, insulin and leptin were reduced, 
reflecting the nutritional status and attenuation of weight gain.
 In the present study, chronic sleep restriction, achieved by the slowly rotating 
drum method, significantly reduced total sleep time. Total sleep decreased from 11 
h on the baseline day to about 4.5 h on sleep restriction days. Most of this sleep 
occurred in the daily 4 h sleep window, but during the daily 20 h forced wakefulness 
periods, inside the rotating drums, rats had occasional micro sleeps as well. 
The latter only added up to approximately one hour of sleep. It cannot be excluded 
that sleep restricted rats experienced some additional sleep like processes, 
perhaps even locally in specific brain regions but this was not accounted for in 
our global analysis of vigilance states. A recent study in rats showed that under 
conditions of sleep deprivation, local clusters of cortical neurons may go offline 
while the rest of the brain stays awake (Vyazovskiy et al., 2011). However, it is 
unlikely that such local processes are sufficient to compensate for the substantial 
deficit of sleep that our rats experienced. 
 Weight gain was attenuated as a consequence of chronic sleep restriction. 
This attenuation appears to be a direct result of increased energy expenditure. 
In control rats, energy intake was higher than energy expenditure, resulting in 
weight gain. In sleep restricted rats, energy expenditure was increased compared 
to controls. One has to keep in mind that energy expenditure measurement by 
means of the doubly labeled water method is a relative underestimation (Kaiyala 
and Ramsay, 2011). This method does not take heat production and anaerobic 
phosphorylation into account. This may explain why SR rats lost some weight 
during the 3-day period when energy expenditure was measured, even though 
energy intake and energy expenditure seem to be in balance. 
 There may be multiple explanations for the increase in energy expenditure in 
sleep restricted rats. First, being awake costs more energy than being asleep 
(Brebbia and Altshuler, 1965;Ryan et al., 1989;Brebbia and Altshuler, 1965;Jung et 
al., 2011). During wakefulness and sleep deprivation, the activity of the sympathetic 
autonomic nervous system is higher than during sleep (for review, see Meerlo et 
al., 2008). As a consequence, body temperature (Bergmann et al., 1989;Bodosi 
et al., 2004;Everson et al., 1994;Sgoifo et al., 2006) and heart rate are increased 
(Everson et al., 1989;Spiegel et al., 2004). As a result, it is not surprising to see 
an increase in energy expenditure during prolonged wakefulness. 
 A second explanation for the increase in energy expenditure might be that our 
sleep deprivation procedure involves a certain degree of (forced) locomotion. 
However, our lab previously found that rats on both a forced or voluntary 
exercise protocol did not show an attenuation of body weight gain, even though 
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both groups of rats walked approximately 5500 m/day (Boersma et al, submitted). 
The latter is ten times as much as the distance walked by SR rats in the present 
study. Therefore, it is unlikely that the daily forced locomotion during sleep 
restriction is the only factor involved in the increase in energy expenditure 
and in turn the attenuation of weight gain. 
 A third explanation for the increase in energy expenditure during sleep 
restriction may be that the procedure causes stress in rats. Various studies 
have shown that uncontrollable stress leads to increased energy expenditure 
(Fuchs and Kleinknecht, 1986) together with an attenuation of weight 
gain (Meerlo et al., 1996). However, in our experiment, plasma levels of 
the stress hormone corticosterone were not changed after 8 days of SR, 
suggesting that forced locomotion as a sleep restriction method is not a major 
stressor.
 It is intriguing that rats in our sleep restriction model do not increase 
their food intake, despite an increase in energy expenditure. Studies by other 
investigators have shown hyperphagia in sleep deprived rats, which may indicate 
an attempt to compensate for the increased energy use (Everson and Crowley, 
2004;Galvao et al., 2009;Koban et al., 2008;Rechtschaffen and Bergmann, 
1995). However, even in those studies, sleep deprived rats lost weight compared 
to controls. We showed that plasma insulin and leptin levels were decreased 
after 8 days of SR. These hormonal changes are likely a reflection of the 
nutritional state of the rats, as seen in literature (Benoit et al., 2004;Levin and 
Keesey, 1998). At the end of the 5 day recovery phase, body weight of SR rats 
remained significantly lower compared to controls, which still seemed to be 
reflected in leptin and insulin levels, even though these levels were no longer 
significantly different from controls. Interestingly, since leptin is a satiety 
signal (Woods and Seeley, 2000;Woods and D’Alessio, 2008), one might 
expect that a decrease in the levels of this hormone would lead to an increase 
in food intake. However, in the present study SR rats refrained from 
increasing their food intake, despite a decrease in leptin and insulin levels.
 Since the decreased levels of leptin and insulin did not lead to increased 
food intake, it may be that these neuroendocrine signals are processed 
differently at the central level. Some sleep deprivation studies in literature 
show hyperphagia together with increased neuropeptide Y mRNA levels and 
orexin/hypocretins levels in the cerebrospinal fluid (Koban et al., 2006;Koban 
et al., 2008;Martins et al., 2010). Thus it may be that the increases in 
these neuropeptides, together with decreased levels of leptin and insulin, are 
necessary to induce hyperphagia. One can speculate that we did not 
see hyperphagia in our experiment due to the fact that these neuropeptides 
are not changed with this particular sleep restriction protocol. 
Future experiments should be performed to verify this. 
 In conclusion, eight days of sleep restriction leads to an attenuation of 
weight gain which is largely explained by an increase in energy expenditure. 




regulatory hormonal factors insulin and leptin. An explanation may be that sleep 
restriction disturbs the regulation of food intake at a more central level such that 
the decrease in plasma leptin and insulin is not sufficient to induce hyperphagia.
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Epidemiological studies have shown an association between short or disrupted 
sleep and an increased risk for metabolic disorders. To assess a possible causal 
relationship, we examined the effects of experimental sleep disturbance on 
glucose regulation in Wistar rats under controlled laboratory conditions. Three 
groups of animals were used: a sleep restriction group (RS), a group subjected 
to moderate sleep disturbance without restriction of sleep time (DS), and a home 
cage control group. To establish changes in glucose regulation, animals were 
subjected to intravenous glucose tolerance tests (IVGTT) before and after 1 or 8 
days of sleep restriction or disturbance. Data show that both RS and DS reduce 
body weight without affecting food intake and also leads to hyperglycemia and 
decreased insulin levels during an IVGTT. Acute sleep disturbance also caused 
hyperglycemia during an IVGTT, yet, without affecting the insulin response. In 
conclusion, both moderate and severe disturbances of sleep markedly affects 
glucose homeostasis and body weight control.
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Introduction
Sleep and metabolism seem to be related. Epidemiological studies have 
established a link between disturbed sleep and increased risk for the development 
of obesity and type 2 diabetes (Cappuccio et al., 2008;Chaput et al., 2006;Chaput 
et al., 2007;Gottlieb et al., 2005). These studies revealed that habitual short sleep 
is a risk factor, independent of classical risk factors such as BMI, food intake and 
reduced exercise [for reviews, see (Knutson et al., 2007;Penev, 2007;Spiegel et 
al., 2009)]. Whether or not these relationships are causal is still a matter of debate 
(Horne, 2008). 
 Experimental studies in both humans and animals have shown clear effects of 
sleep deprivation on body temperature, food intake, body weight gain and energy 
expenditure (Banks and Dinges, 2007;Nedeltcheva et al., 2009;Rechtschaffen 
and Bergmann, 1995;Vaara et al., 2009). Sleep deprivation also leads to changes 
in the activation of the sympathetic nervous system, to reduced levels of leptin 
and to increased levels of ghrelin in the general circulation (Taheri et al., 2004). 
Finally, a number of recent experimental studies suggest that even mild sleep 
disturbance leads to glucose intolerance, the first step in the development of type 
2 Diabetes (Spiegel et al., 1999;Tasali et al., 2008). 
 While epidemiological studies mainly focused on mild but chronic sleep 
disturbances, laboratory studies mostly focus on the consequences of acute 
and short-lasting sleep deprivation. Frequent or chronic sleep disruption may 
gradually lead to changes in brain and body that are not noticeable after acute 
sleep deprivation (Meerlo et al., 2002;Novati et al., 2008;Roman et al., 2005). 
Yet, studies on metabolism and glucose regulation under conditions of mild but 
chronic sleep disturbance in a controlled experimental setting are scarce (Everson 
and Szabo, 2009;Spiegel et al., 1999). Therefore, in the current study we applied 
an animal model to investigate the effect of chronically disturbed sleep on glucose 
homeostasis. To this end, rats were subjected to a series of intravenous glucose 
tolerance tests (IVGTT) before and after a period of either moderate sleep 
disturbance or severe sleep restriction. To compare the effects of acute and 
chronic sleep disturbance, the experiment was performed after a period of 1 or 8 
days of sleep disturbance. 
Methods
Animals and housing
Male Wistar rats (weight ± 320g; Harlan Netherlands BV, Horst, The Netherlands) 
were individually housed in Plexiglas cages in a climate-controlled room (21 °C ± 1) 
under a 12h: 12h light-dark cycle (lights on at 10:00 am). Animals were maintained 
ad lib on medium fat food (45% fat; Arie Blok Diervoeding B.V., Woerden, The 
Netherlands). Water was available ad lib throughout the study. Food intake and 
body weights were measured daily. Experiments were approved by the Ethical 





All animals were instrumented with chronic heart catheters bilaterally in the jugular 
vein (Steffens, 1969) allowing stress free blood sampling during an intravenous 
glucose tolerance test (IVGTT). Surgeries were carried out under general 
isoflurane (2%) anesthesia. Animals had at least 10 days to recover before the 
start of the experiments. Cannulas were checked every week for patency.
Sleep restriction and sleep disturbance
The animals were divided over three groups (see Figure 1): a sleep restricted 
group (restricted sleep: RS), a moderately sleep disturbed group (disturbed sleep, 
DS) and a home cage control group (controls). The sleep restricted animals (RS) 
were allowed to sleep in their home cage for only 4 hours per day at the beginning 
of the light phase. During the remaining 20 hours, the rats were kept awake by 
placing them in slowly rotating drums (diameter 40cm), rotating at a constant speed 
of 0.4 m/min (Novati et al., 2008;Roman et al., 2005). The animals of the sleep 
disturbed group (DS) were forced to walk in the rotating drums for a total of 10 
hours/day with the aim to disturb their normal sleep-wake cycle without restricting 
their sleep time. The 10h of forced activity in this group was divided in 4 blocks 
of 2 or 3h with 3 or 4h of rest in between (Figure 1). The animals of the DS group 
walked at double speed (0.8 m/min) and therefore covered the same distance as 
the RS animals (0.48 km/day). For comparison, rats run approximately 2-3 km/day 
when allowed to run voluntarily (Scheurink et al., 1999). Both RS and DS animals 
spent the first 4h of the light phase in their regular home cages for IVGTT’s and 
blood sampling. All animals were habituated to the experimental conditions by 
placing them in the drums for 1-2h for 3 consecutive days before the onset of the 
experiments. Control animals were left undisturbed in their home cage. 
Intravenous glucose tolerance test and chemical analyses
To assess the effects of sleep restriction and/or sleep disturbance on glucose 
regulation, rats were subjected to a series of intravenous glucose tolerance tests 
(IVGTT). The IVGTT’s were performed during the third and fourth hour of the 
light phase. Food was removed at lights on and rats were connected to the blood 
sampling and infusion tubes at least one hour before the IVGTT. During the IVGTT, 
a 15% glucose solution was infused for 30 minutes at a rate of 0.1 ml/min. The 
start of the infusion was designated time point t = 0 min. Blood samples (0.2 ml) 
for determination of blood glucose and plasma insulin levels were taken before, 
during and after the infusion of glucose at time points t = -10, -1, 5, 10, 15, 20, 25, 
30, 35, 40 and 50 min. Note that the glucose infusion prevented any hypovolemic 
effect of the blood sampling. Blood samples were collected in EDTA (20μL/ml 
blood) containing tubes on ice. Blood was centrifuged at 2600g for 10 min and 
plasma was stored at − 20 °C until analysis. Blood glucose levels were measured 
by Hoffman’s ferrocyanide method and plasma levels of insulin were measured by 
Millepore Rat Insulin Radioimmunoassay (Linco Research, St Charles, MO, USA).
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Experimental design
Two experiments were performed. Experiment 1 was designed to study 
glucose homeostasis under conditions where sleep was disrupted or restricted 
chronically. In this experiment, the animals were subjected to an IVGTT before 
(pre-experimental baseline) and after an 8-day period of sleep disturbance (RS 
or DS). Rats that remained in their home cage without any sleep disturbance 
served as controls. Experiment 2 served as a control experiment for the chronic 
sleep disturbance study and assessed the effects of acute sleep disturbance. 
In this second experiment a single IVGTT was performed after 1 day of sleep 
disturbance. In both experiments, blood samples were collected for measurement 
of glucose and insulin levels. In the second experiment an additional 0.1 ml blood 
sample was taken at t = -10 minutes for determination of plasma corticosterone 
levels (ImmuChem 125I Corticosterone Radioimmunoassay, MP Biomedicals, 
Orangeburg, NY, USA).
Statistical analysis
Data are expressed as averages ± SEM. Body weight is expressed as the change 
in weight relative to day 0 (the onset of sleep disturbance). The effects of RS and 
DS on food intake and body weight, as well as glucose and insulin responses to 
IVGTT were tested by comparing the experimental and control groups with each 
other and, in Experiment 1, with the pre-experimental baseline using repeated 
measures analysis of variance (ANOVA). When appropriate, a posthoc Tukey test 
was applied to establish differences between the three groups (controls, RS and 
DS). P < 0.05 was considered statistically significant.
Figure 1: Schematic overview of the sleep disturbance protocols for the restricted sleep group (RS), disturbed 
sleep group (DS), and control group. For each treatment group, periods of wakefulness induced by forced 
locomotion are shown in light grey. The RS group was subjected daily to one consolidated block of 20h forced 
activity while the DS group was subjected to blocks of 2-3h forced activity interspersed by 3-4h blocks of rest. 





The average 24 hour food intake before, during and after the treatment for 
the different groups is shown in figure 2A. There were neither differences in 
food intake between the 3 groups, nor changes over time within the groups. 
Body weights are shown in figure 2B. The RS and DS animals were significantly 
lower in body weight than the home cage controls already after 2 days of sleep 
disturbance (Repeated Measures ANOVA: F(36,486)=11.02, P<0.001; posthoc 
Tukey Test: controls vs. RS P<0.01 and controls vs. DS P<0.01). There were 
no body weight differences between the RS and the DS animals.
 Figure 3 depicts the glucose and insulin levels before, during and after the 
30-min intravenous infusion of glucose, both under baseline (pre-experimental) 
conditions and after 8 days of sleep disturbance (RS and DS versus controls). 
In all groups, intravenous infusion of glucose led to an increase in both blood 
glucose and plasma insulin levels. After termination of the infusion, both glucose 
and insulin returned to pre-infusion levels. Eight days of sleep disturbance 
markedly changed the glucose and insulin responses to an IVGTT. Blood 
glucose levels were higher and plasma insulin levels were lower in the RS 
and DS animals compared to the pre-experimental IVGTT levels (Glucose 
RS: F(10,140)=10.05, P<0.0001; Glucose DS: F(10,160)=9.64, P<0.0001; 
Insulin RS: F(10,150)=10.53, P<0.0001; Insulin DS: F(10,160)=8.97, P<0.0001). 
Also in comparison to the home cage controls, glucose levels were higher and 
insulin levels were lower in both experimental groups (Glucose: F(20,200)= 
3.37, P<0.0001; posthoc Tukey Test: RS vs. controls P<0.05 and DS vs. 
controls P<0.05; Insulin: F(20,190)=3.70, P<0.0001; posthoc Tukey Test: RS 
vs. controls P<0.01 and DS vs. controls P<0.05). No differences were found 
between the RS and DS rats.        
 Figure 4 shows the glucose and insulin levels before, during and after the 
glucose infusion after a single day of sleep disturbance. In both the RS and DS 
animals, glucose levels were significantly higher than the levels in undisturbed 
home cage controls (F(21,210)=12.49, P<0.0001; posthoc Tukey Test: RS 
vs. controls P<0.001 and DS vs. controls P<0.001) There were no differences 
between the groups with regard to the plasma insulin response to an IVGTT 
after one day of sleep disturbance.
 In Experiment 2, after 1 day of RS or DS, at time point t = -10 min immediately 
preceding the IVGTT, plasma levels of corticosterone were low and not 
different between the groups (RS: 1.4 ± 0.2 μg/dl, DS: 1.3 ± 0.1 μg/dl, controls: 
2.4 ± 0.2 μg/dl).
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Figure 2: Average daily food intake (a) and body weight (b) in the baseline, experimental and recovery phase 
of the experiment for RS (n=11), DS (n=12) and control (n=7) animals. The horizontal grey bars at the bottom 
of the graphs represent the 8 day period of RS or DS. Data are average values ± SEM. Asterisks indicate a 




Figure 3: Blood glucose and plasma insulin levels in response to a 30-min intravenous glucose infusion 
after 8 days of sleep restriction (graphs C and F, n=11), sleep disturbance (graphs B and E, n=12) 
or control (graphs A and D, n=7). Each graph presents the glucose or insulin profiles under 
pre-experimental baseline conditions (Baseline: open circles) and after 8 days of sleep disturbance 
(Experiment: closed circles). The horizontal grey bars at the bottom of each graph represent the 30 min of 
15% glucose infusion. Data are average values ± SEM. Asterisks indicate a significant difference between 
baseline and experimental conditions (* P<0.05).
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Figure 4: Blood glucose (a) and plasma insulin levels (b) in response to a 30-min intravenous glucose 
infusion after 1 day of sleep restriction (closed triangles, n=8), sleep disturbance (closed circles, n=8) or 
control (open circles, n=8). The horizontal grey bars at the bottom of the graphs represent the 30 min of 15% 
glucose infusion. Data are average values ± SEM. Asterisks indicate a significant difference between sleep 
restricted rats and controls (* P<0.05) and # indicates a significant difference between sleep disturbed rats 





This study shows that eight days of sleep disturbance markedly interferes with 
body weight maintenance and glucose metabolism in rats. The main findings 
were: 1) chronic sleep disturbance reduces body weight without changes in food 
intake; 2) chronic sleep disturbance leads to hyperglycemia and a concomitant 
reduction in the insulin response to an IVGTT; 3) acute sleep disturbance also 
leads to hyperglycemia without changes in the insulin response to an IVGTT; 
4) the metabolic effects of moderate sleep disturbance and more severe sleep 
restriction are remarkably similar.
 The elevated glucose levels that occurred after both short and long term sleep 
disturbance confirm data from previous studies in humans in which was found that 
moderate sleep restriction or even suppression of sleep intensity without affecting 
sleep time may lead to glucose intolerance (Spiegel et al., 1999;Tasali et al., 2008). 
In our study, the increase in blood glucose during the IVGTT already occurred 
after one day of sleep disturbance. The data from the chronic sleep disturbance 
experiment might suggest that the elevated glucose levels are caused by a reduced 
insulin response. However, the finding of hyperglycemia without changes in plasma 
insulin response after acute sleep disturbance makes this explanation less likely. 
An alternative explanation might be that the hyperglycemia is caused by increased 
HPA-axis activity reflecting the stress of sleep disturbance. To test this possibility 
we measured plasma corticosterone levels in the sleep disturbed animals just prior 
to the infusion of glucose. Since corticosterone levels were not different between 
the groups, elevated HPA-axis activity can also not explain the hyperglycemia 
after sleep disturbance. Therefore, the reason for the hyperglycemia following 
both short and long term sleep disturbance remains unclear. Our current studies 
focus on the hypothesis that this hyperglycemia may be secondary to changes in 
hypothalamic orexin, a neuropeptide known to be involved in both the sleep/wake 
cycle and glucose metabolism (Sakurai, 2007;Tsujino and Sakurai, 2009;Yi et al., 
2009). A number of recent studies suggest that REM sleep deprivation increases 
orexin immunoreactivity in the lateral hypothalamic area and orexin levels in the 
CSF, which may underlie some of the metabolic changes described after restricted 
or disrupted sleep (Galvao et al., 2009;Pedrazzoli et al., 2004).
 Eight days of sleep disturbance caused a reduction in body weight together with 
a decrease in basal levels of glucose and insulin and a decrease in IVGTT levels 
of insulin. The literature suggests that the lower levels of glucose and insulin and 
the attenuated insulin response to the glucose tolerance test are most likely a 
direct consequence of the drop in body weight (Redman and Ravussin, 2009). 
 Surprisingly, the weight loss in our rats was not accompanied by a change in food 
intake, which may suggest that sleep disturbance leads to increased daily energy 
expenditure. The latter indeed is supported by data in the literature (Everson, 
1995;Rechtschaffen and Bergmann, 1995). One cause of an increased energy 
expenditure in our protocol of sleep disturbance might be the forced locomotion 
in the rotating drums. However, one should note that in both the RS and 
DS condition the rats walked only 480 m/day, which is less than 20% of the 
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distance they would voluntarily run in a running wheel (Scheurink et al., 1999). 
Furthermore, although long term exercise may lead to improved insulin sensitivity 
and therefore reduced plasma insulin levels (Borghouts and Keizer, 2000), in rats, 
it does not lead to extensive weight loss and/or hyperglycemia (Donovan and 
Sumida, 1990). Therefore, the decrease in body weight and hyperglycemia in our 
study are not likely a result of the mild increase in activity involved in our sleep 
disturbance protocols.
 The metabolic changes after sleep disturbance were similar in the RS and 
DS animals. This was unexpected because the degree of sleep restriction 
was markedly different between the two groups. The DS rats were subjected 
to a disruption of the normal sleep-wake cycle without restriction of their sleep 
time, whereas the RS rats were genuinely sleep restricted. Based on this 
observation, we speculate that the metabolic consequences of sleep curtailment 
are mainly related to the occurrence of frequent sleep interruptions and a 
disturbed sleep-wake cycle rather than sleep loss per se. In other words, it is 
the quality rather than the quantity of sleep that is important. Indeed, a recent 
study in humans found that suppression of sleep intensity without changes in total 
sleep time was sufficient to cause glucose intolerance and a decreased acute 
insulin response (Tasali et al., 2008). Patients suffering from obstructive sleep 
apnea (OSA) provide comparable evidence (Bandla and Gozal, 2000;Svanborg 
and Guilleminault, 1996). Total sleep time in OSA patients is not 
dramatically altered, still there are direct correlations between OSA and 
obesity, type 2 diabetes and cardiovascular diseases (Vgontzas et al., 2003). 
The opposite is true as well: modest weight gain or weight loss lead to 
a significant worsening or improvement, respectively, of sleep apnea in 
middle-aged individuals (Peppard et al., 2000;Pillar and Shehadeh, 2008). 
Thus, several lines of evidence together suggest that disturbed sleep by 
itself is sufficient to affect glucose homeostasis. 
 In conclusion, our data reveal that disturbance of the regular sleep-
wake rhythm has a marked effect on glucose homeostasis and body weight 
control. Sleep disturbance directly leads to glucose intolerance and 
hyperglycemia and, on the long term, to weight loss accompanied with reduced 
insulin responses. The data further suggest that a disturbance of the normal 
sleep pattern, even without restriction of total sleep time, is sufficient to affect 
glucose metabolism and body weight maintenance.
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There are large individual differences in the success rate of exercise intervention 
programs aimed at the prevention and treatment of obesity related disorders. 
In the present study we tested the hypothesis that differences in coping style 
may have repercussion for the success rate of these intervention programs. 
To this end we tested the insulin responses before and after voluntary wheel 
running, via intravenous glucose tolerance tests (IVGTT), in both passive (insulin 
resistant) Roman Low Avoidance (RLA) and proactive (insulin sensitive) Roman 
High Avoidance (RHA) rats. To control for the potential difference between 
voluntary and forced exercise, we also included RLA and RHA rats that were 
subjected to forced-running. We found that 1) when given the opportunity to run 
voluntarily in a running wheel passive RLAs run more than proactive RHAs, 2) 
voluntary exercise leads to a normalization of the insulin response during an IVGTT 
in the RLA rats, and 3) there were no behavioral and physiological differences 
in efficacy between voluntary and forced running. We thus conclude that 
exercise, both forced and voluntary, is a successful lifestyle intervention for the 
treatment of hyperinsulinemia, especially in individuals with a passive coping style.
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Introduction
Successful life style intervention may halt the ever increasing prevalence of 
metabolic disorders such as obesity, the metabolic syndrome and type 2 diabetes 
(Dunstan et al., 1997; Lindstrom et al., 2006). Exercise-based intervention 
programs are particularly successful (Vanninen et al., 1992; Torjesen et al., 1997), 
for a recent review see (McCall and Raj, 2009). Exercise reduces body adiposity, 
improves glucose tolerance and increases insulin sensitivity (DeFronzo et al., 
1987; Ebeling et al., 1993; Hughes et al., 1993; Mayer-Davis et al., 1998; Afonso 
and Eikelboom, 2003; Alessio et al., 2005). There are, however, large individual 
differences in the success rate of exercise intervention programs (Teixeira et 
al., 2004), partly due to the large individual differences in the susceptibility for 
these metabolic disorders (recently reviewed in (Andreassi, 2009)). Our working 
hypothesis is that differences in coping style may explain the large individual 
variation in the success rate of exercise interventions programs in metabolic 
disorders such as type 2 Diabetes and the metabolic syndrome.
 Differences in coping style are a wide-spread phenomenon in the animal 
kingdom (Careau et al. 2010; Wolf et al., 2008). This is, however, largely ignored 
in animal studies modeling the development of type 2 Diabetes, insulin resistance 
or the metabolic syndrome. In our most recent studies, we have filled in this gap 
using the Roman High and Low Avoidance rat selection lines (Boersma et al. 
2009; Boersma et al. 2010; Boersma et al., 2011b). Rats from these selection lines 
are different at the level of several neuroendocrine, cardiovascular and metabolic 
parameters (Corda et al., 1997; Giorgi et al., 2003; Boersma et al., 2009), but 
do also differ in emotional reactivity and coping style. Roman Low Avoidance 
(RLA) rats are highly emotional individuals with a passive coping style, Roman 
High Avoidance (RHA) rats are (pro)active rats with low emotional reactivity. We 
recently demonstrated that the passive animals display, already at normal weight, 
several characteristics of the metabolic syndrome, such as insulin resistance, 
visceral adiposity and hypertension (Boersma et al. 2009; Boersma et al. 2010; 
Boersma et al. 2011a; Boersma et al., 2011b). We have extended and confirmed 
these findings in passive and proactive individuals in outbred wild-type Groningen 
rats, in which coping style appeared to predict changes in metabolic profiles 
analogous to those observed in the RHA/RLA rats (Boersma et al. 2010; Boersma 
et al. 2011b).
 In the present study we particularly focused on the importance of differences 
in coping style on the potential beneficial effect of exercise on insulin resistance 
and visceral adiposity. To this end, we performed a series of experiments in which 
the insulin response during an intravenous glucose tolerance test (IVGTT) was 
measured in both passive (insulin resistant) RLA and proactive (insulin sensitive) 
RHA rats, under sedentary conditions and after 18 days of exercise in a running 
wheel.
 In most animal studies, exercise consists of voluntary running in a wheel. The 
voluntary running in rats is used to mimic exercise programs in humans. However, 




stressful and/or aversive. This means that there is a discrepancy between 
voluntary exercise in the rat model and forced exercise in the human. Therefore, 
to control for the potential difference between stressful and stress-free exercise, 




The experiments were approved by the local animal experimental welfare and 
care committee (DEC, Groningen, the Netherlands). Roman High (RHA) and 
Low (RLA) Avoidance rats, obtained from a breeding colony at the Clinical 
Psychopharmacology Unit (APSI) of the University of Geneva, were housed in 
a room controlled for temperature and humidity (20 ± 2 °C; 60%). The room was 
kept at a 12-12 hours light-dark cycle (lights on = CT0 at 01:00 hrs., lights off = 
CT12 at 13:00 hrs.). The rats were fed a standard lab chow diet (Hope Farms, 
Arie Blok Diervoeding, Woerden, NL; 3.7 kcal/g, 14 % fat). Food and water was 
available ad libitum.
Experimental design
The following experiments were performed: 1) Experiment 1 in which both RHA 
and RLA rats were submitted to an intravenous glucose tolerance test (IVGTT) at 
baseline and after 18 days of voluntary wheel running and 2) Experiment 2 in which 
both RHA and RLA rats were submitted to IVGTTs at baseline and after 18 days 
of forced wheel running. For both studies, the rats underwent surgery to place two 
indwelling jugular vein catheters for infusion and blood sampling (Steffens, 1967). 
Rats were accustomed to the infusion and blood sample procedures before the 
onset of the experiments (Steffens, 1969). The experiments started two weeks 
after surgery. Body weights and food take was measured daily throughout the 
experiment. The experimental design is summarized in figure 1.
Experiment 1
Twelve rats (6 RHA and 6 RLA) were housed in standard cages (24x24x32 cm). 
Two weeks after surgery, at day -14, a baseline IVGTT was performed. At day -10, 
the rats were transferred to standard running wheel cages (Nalgene polycarbonate 
running wheel cages [50-27-36 cm]) with free access to a running wheel 
(diameter 27cm, Mini Mitter, Oregon, USA). The rats were allowed to habituate 
to the wheel running for 10 days. During this habituation period running activity 
typically increases after which it stabilizes. After habituation, the rats were allowed 
to run voluntary for 18 days (intervention period: day 0 until day 18). A second 
IVGTT was performed on day 18. Four days later, the rats were sacrificed for 
carcass analysis.
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Experiment 2
Sixteen rats (8 RLA and 8 RHA) were housed in standard cages (24x24x32 cm). 
A baseline IVGTT was performed at day -14. At day -10, the rats were transferred 
to forced activity cages (TSE, Bad Homburg, Germany). These cages contain 
running wheels with a diameter of 25 centimeter that force the rat to run. Both 
running speed and time spent on running are controlled. All animals were forced 
to run in a schedule that mimicked the voluntary running activity patterns of the 
pro-active RHA rats that participated in Experiment 1 (see Figure 3B). Since we 
observed that rats are running in bouts of circa 5 minutes, we decided to force the 
animals to run in a schedule of 5 minutes running and 5 minutes rest. The speed 
(max 20 m/min) was adjusted so that the total distance per hour was similar to that 
of the RHA rats. The rats were accustomed to the forced running paradigm for 10 
days (day -10 until day 0). Intensity and duration was slowly built up, in parallel to 
the increased running in the habituation period in the voluntary running animals in 
Experiment 1. Running only took place in the dark phase, and the running pattern 
mimicked the average hourly running activity patterns of the voluntary running 
RHA rats. Hereby the forced running rats, similar to voluntary running rats, had 
ample time to eat, sleep and drink, and effects of alterations in circadian rhythms 
were minimized. During the intervention the rats were forced to run 5000 m/day. 
The forced activity intervention period lasted from day 0 until day 18. A second 
IVGTT was performed on day 18. Four days later, the rats were sacrificed for 
carcass analysis.
Intravenous glucose tolerance test
At the day of an IVGTT, food was removed at the beginning of the light phase 
at CT 0. The IVGTTs were performed in the light phase, between CT 4 and CT 
6. An IVGTT consisted of 30 minutes infusion of 15 mg glucose in 0.1 ml saline 
per minute (total 450 mg in 3 ml). Before the onset of the infusion, two baseline 
samples (0.2 ml) were taken at time points t = -11 and 1 minutes. The infusion of 
glucose was started at time point t = 0 minutes. Additional blood samples were 
taken at time points t = 5, 10, 15, 20, 25, 30, 35, 40, and 50 minutes. A total blood 
volume of 2.2 ml was taken. Blood samples were kept on ice and stored in files 
with 10 μl EDTA (0.09g/ml). For glucose determination 50 μl of full blood with 




450 μl Heparin solution (2%) was stored at -20°C until analysis. Blood glucose 
levels were determined using the ferry-cyanide method (18) in a Technicon auto 
analyzer. The remaining blood was centrifuged for 15 minutes and plasma was 
stored for insulin and corticosterone determination. Plasma levels of insulin and 
corticosterone were measured with commercial radioimmunoassay (RIA) kits 
(Linco Research and.M P Biomedicals).
Carcass analysis
An extensive carcass analysis was performed 4 days after the last IVGTT. 3 
hours before lights off, rats were sacrificed using an overdose of pentobarbital. 
Epididymal and retroperitoneal fat pads and the liver were taken out and weighed. 
The skin with the subcutaneous fat was removed from the carcass. The liver, skin, 
and carcasses were dried at 80 °C for 5 days. The fat content was determined 
by extracting the fat from the tissue using a petroleum based Soxlet fat extractor. 
After fat extraction the tissue was dried for 5 days again. The difference between 
dry tissue weight before and after fat extraction provides information on the fat 
content of the tissue.
Data analysis
Food intake and body weight data are presented as daily averages with standard 
error of the mean (SEM). Average running wheel activity was calculated as 
averages from day 0 until day 18 for each individual animal. Glucose and insulin 
levels are presented in group averages with standard error of mean. Statistical 
differences between groups were determined with repeated measures ANOVA 
followed by Tukey post-hoc test using coping style and type of intervention as 
between subjects factors and time of measurement as within subjects factor. 
The area under the curves (AUC) of the insulin responses were calculated and 
averaged. Percentage fat mass was calculated by dividing total dry fat mass by 
total dry lean body mass and multiplying this with 100%. Fat mass and weight of 
the different fat pads are presented as group averages with standard error of the 
mean. Differences in the area under the insulin response curve, and the body 
composition were statistically tested with one-way ANOVA followed by Tukey post 
hoc analysis using coping style and type of intervention as the between subject 
factors. All statistical analyses used a 5% confidence interval.
Results
Figure 2 displays body weight gain (A) and food intake (B) of the different groups 
during the intervention period from day 0-18. There were no differences in food 
intake or body weight gain among any of the groups. In all groups, food intake 
was higher during the intervention period when compared to the intake during 
the baseline period (baseline: 101 ± 4.8 kcal/day; intervention: 120 ± 5.6 kcal/
day; F(1,27)= 4.562, p<0.05). Figure 3 displays the running activity of all 
groups. In Experiment 1, RLA rats ran significantly more than RHA rats 
(F(1,15)= 9.332, p< 0.01). 
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Blood glucose and plasma insulin levels are presented in Figure 4. There were 
no significant differences in blood glucose levels among the groups. Insulin 
responses were significantly different (F(5,39)= 6.294, p<0.01): 1) at baseline, 
when RLAs have much higher levels than RHAs (p<0.01),   2) in the RLAs, in 
which the baseline levels were much higher than those after 18 days of both 
voluntary and forced exercise (voluntary running p<0.01; forced running p<0.01) 
and 3) in the RHAs when baseline levels were higher than those after 18 days 
of voluntary but not forced exercise (voluntary running p<0.05; forced running 
p=0.103). There were no differences in plasma insulin responses between the 
voluntary runners and the forced runners, both under baseline conditions and after 
18 days of exercise.
 Corticosterone levels at the end of the light phase were not different between 
the forced and voluntary running rats under any circumstances (RLA baseline: 250 
± 35.3 ng/ml; RHA baseline: 225 ± 29.3 ng/ml; RLA voluntary running: 242 ± 29.7 
ng/ml; RHA voluntary running: 226 ± 25.3 ng/ml; RLA forced running: 263 ± 29.7 
ng/ml; RHA forced running: 233 ± 25.26 ng/ml). Baseline levels of corticosterone 
at circadian peak level tended to be higher in the passive RLAs when compared to 
the proactive RHAs, but this difference did not reach statistical significance.
 Carcass analysis showed there were no differences in the percentage of body 
fat at the end of the study (RLA voluntary running: 35.9 ± 0.47 %; RHA voluntary 
running: 34.9 ± 0.54 %; RLA forced running: 33.3 ± 0.56 %; RHA forced running: 
33.1 ± 0.62 %). The distribution of body fat was however different between 
the groups: passive RLAs have relatively more fat in the epididymal depot in 
comparison to proactive RHAs (RLA voluntary running: 4.42± 0.24 g; RHA 
voluntary running: 3.91 ± 0.21 g; RLA forced running: 5.8 ± 0.49 g; RHA forced 
running: 3.6 ± 0.26 g; (F (3,25) = 6.426 p<0.05)). There were no differences 
between RLAs and RHAs in the amount of fat distributed in the retroperitoneal fat 
depot (RLA voluntary running: 7.7 ± 0.77 g; RHA voluntary running: 7.1 ± 0.69 g; 




Figure 3: Running activity in experiments 1 and 2. White symbols = voluntary running RLA rats, Black symbols 
= voluntary running RHA rats, Grey symbols = forced running rats of both strains * indicates a significant 
difference between voluntary running RLAs and RHAs. 
Figure 2: Body weight gain and food intake of passive and proactive rats that ran voluntarily or forced.
Black circles = proactive forced runners (n=8), white circles = passive forced runners (n=8), 
black triangles = proactive voluntary runners (n=6), white triangles = passive voluntary runners (n=6). 
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Figure 4: Blood glucose (A and B) and plasma insulin (C and D) levels before, during and after an IVGTT 
at baseline and after 18 days voluntary or forced running in both RLAs (A and C) and RHAs (B and D). 
Baseline values in experiment 1 and 2 are combined in one graph. Black triangles = baseline, light grey 
circles = voluntary runners, dark grey squares = forced runners. Area under the insulin curve at baseline and 
after 18 days of voluntary and forced running in RLA (E) and RHA (F) rats. Black bars = baseline voluntary 
runners, medium grey bars = 18 days voluntary running, dark grey bars = baseline forced runners, light grey 
bars = 18 days forced running. vr = voluntary running, fr = forced running. * indicates a significant difference 





The aim of the current study was to investigate the interaction between coping 
style and exercise in relation to the treatment of hyperinsulinemia. The major 
findings of this study were: 1) when given the opportunity to run voluntarily in a 
running wheel, passive RLAs run more than proactive RHAs, 2) voluntary exercise 
leads to normalization of the insulin response during an IVGTT in the RLA rats, 
and 3) there are no behavioral and physiological differences between voluntary 
and forced running. 
 Consistent with our previous studies, passive RLA rats displayed a much higher 
insulin response to an intravenous glucose tolerance test under baseline conditions 
when compared to  the RHA rats (Boersma et al., 2009). Exercise completely 
normalized this elevated insulin response to control levels indicating that exercise 
is a successful life style intervention for the treatment of hyperinsulinemia, in 
particular in rats with a passive coping style.  
 The most interesting finding is the increased running activity in the passive RLA 
rats when they were allowed to run voluntarily. This is remarkable since these 
so-called passive rats are generally characterized as having lower locomotor 
activity. This ‘passive’ behavior was observed in several different experimental 
conditions such as the open field test, the Porsolt forced swim procedure and the 
elevated plus maze test (Ferre et al., 1995; Steimer and Driscoll, 2005; Smith and 
MacKenzie, 2006). However, these tests are all short term responses to unfamiliar 
conditions, whereas in our study we monitored the internal motivation to be active 
in a familiar environment.
 Increased running in the RLAs resulted in the normalization of the insulin 
response during an IVGTT, which is a strong indication of improvement of insulin 
sensitivity. Such a phenomenon, i.e. increased spontaneous wheel running 
activity in metabolically deranged rodents has been reported before, among 
others in overweight animal models such as the OLEFT rat (Bi et al., 2005) 
and the MC4 knockout mouse (Haskell-Luevano et al., 2009). Both the OLEFT 
and the MC4 knockouts have an obese and insulin resistant phenotype under 
sedentary conditions, but compensate for this by increased activity when allowed 
to run spontaneously in wheels, leading to normalization of their body weight. 
In the present study, we observe that presumably insulin resistant rats show 
increased running to normalize their insulin sensitivity. Therefore it is tempting to 
speculate that the increased running may be considered as a behavioral strategy 
to compensate for the reduced insulin sensitivity in the sedentary state. Like 
insulin, muscular contractile activity causes glucose transporter type 4 (GLUT4) 
translocation and increases glucose uptake (Ploug and Ralston, 1998), hence 
exercise would benefit RLA rats more than RHA rats. Along these lines, it may be 
speculated that exercise has a larger impact on glucose availability to neuronal 
circuitry (Bequet et al., 2000) in RLA rats than in RHA rats, which might be a 
mechanisms by which RLA rats sustain a higher level of running wheel activity 
than RHA rats. Another implication of these results is that the sedentary state, at 
least in rodents, should not be considered as a proper control condition because 
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physical activity and health are inevitably linked (Booth et al., 2006). A point that 
is illustrated by the healthy insulin profiles in the voluntary running RLA rats.  
 We argued in the introduction section that the translational value of voluntary 
exercising animals might be limited, because humans subjected to exercise-based 
interventions may perceive it as a stressful workload. Our second study therefore 
investigated difference in the efficacy of forced and voluntary exercises in the RLA 
rats. We showed that both forced and voluntary running resulted in “normalized” 
insulin responses to an IVGTT in the RLA rats. This suggests that the exercise 
itself rather than the voluntary or forced nature of the running determines the 
beneficial effects of the wheel running on insulin sensitivity. In the current study, 
the amount of forced running was based on the average voluntary running activity 
of proactive RHA rats. Proactive rats were shown to run less voluntarily than 
passive rats. Since this forced running improved insulin signaling in the RLA rats, 
one may argue that the amount of running might not be crucial for the attenuation 
of hyperinsulinemia in the RLAs.
 The current set-up was chosen to minimize the stress of the forced running 
paradigm, especially since it might be perceived differently in RLA and RHA rats. 
A difference in perception of the workload imposed on them might, however, prove 
important when studying exercise based lifestyle interventions. In humans it is 
argued that individuals with proactive personality traits have a lower perception 
of exertion and endure higher amounts of exercise than individuals with passive 
personality traits (Hassmen et al., 1993). Nevertheless, the observation that there 
are no behavioral and physiological differences between voluntary and forced 
running animals, strengthens the face validity of the voluntary rat model for 
translation to human studies. Finally, we may conclude that exercise, either forced 
or voluntary, may serve as a successful lifestyle intervention for the treatment of 
hyperinsulinemia, especially in rats with a passive coping style.
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CH. 5
Shift work in rats affects 
body weight and food 










Epidemiological and clinical studies suggest that working in shifts may lead to 
health problems and contribute to the development of obesity and type 2 diabetes. 
In support of this idea, an experimental study in rats showed that a simulated shift 
work protocol leads to loss of glucose rhythmicity and increased body weight. 
Based on these findings, we hypothesized that simulated shift work in rats will 
lead to glucose intolerance. Two groups of rats were included in this experiment. 
One group was subjected to a shift work protocol for 14 days. Rats were forced 
to be active for 8h per day during the light phase, i.e., their normal resting phase, 
which was achieved by placing them in slowly rotating drums. The second 
group was forced to be active for 8h during the dark phase, i.e., their normal 
active phase. All rats were subjected to an intravenous glucose tolerance test 
(IVGTT) before and after 14 days of (shift) work. Rats subjected to the shift 
work protocol showed a gradual increase in food intake during the forced 
waking period but immediately returned to their normal baseline pattern of food 
intake during the recovery period following shift work. Despite this shift in food 
intake, total food intake was not changed, body weight was slightly attenuated 
and no effect was found on glucose homeostasis. In conclusion, our current 
data do not support the hypothesis that shift work leads to disturbed metabolic 
regulation and glucose intolerance.
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Introduction
Shiftwork is a common phenomenon in our modern industrialized societies. Several 
epidemiological and clinical studies suggest that working during the normal sleep 
phase on a regular basis is a risk factor for the development of various diseases 
including metabolic disorders such as obesity and type 2 diabetes (de Assis 
et al., 2003;Knutsson, 2003;Nagaya et al., 2002;van Amelsvoort et al., 1999). 
The negative metabolic consequences of shift work may be mediated by a 
variety of different factors, e.g., circadian disturbance, sleep disturbance, altered 
food intake and increased snacking behavior (for review see: (Akerstedt, 2003; 
Antunes et al., 2010;Atkinson et al., 2008;Boggild and Knutsson, 1999;Knutsson, 
2004). Unfortunately, few experimental and well-controlled studies have been 
devoted to this topic.
 A study in rats demonstrated that 8h of forced activity during the sleep phase 
shifted food intake from the normal activity phase to the forced activity phase 
(Salgado-Delgado et al., 2008). This was accompanied by an increase in 
body weight and loss of glucose rhythmicity. Since there were no changes in 
the expression profiles of the circadian clock proteins PER1 and PER2 in the 
suprachiasmatic nucleus (SCN), these observations indicate that in rats shift work 
leads to an uncoupling of metabolic function from the biological clock in the SCN. 
 Loss of glucose rhythmicity per se does not provide information on the effect 
of shift work on glucose homeostasis. An intravenous glucose tolerance test 
(IVGTT) is more informative in this respect, since an IVGTT is used to evaluate 
insulin response and glucose clearance after glucose infusion. It has been shown 
previously that an IVGTT is a successful tool to study glucose homeostasis 
(Strubbe and Bouman, 1978).
 In the present study, we assessed the effect of shift work on food intake patterns, 
body weight and glucose homeostasis. The experiment included two groups of 
rats that were subjected to forced activity during different phases of the circadian 
cycle. The first group was forced to be active during the light (inactive) phase 
(shift work group). A second group was forced to be active during the dark 
(active) phase and was therefore not disturbed in their normal circadian 
organization (control work group). The rats were subjected to IVGTTs before 
and after a 2-week period of control work or shift work. We first assessed if shift 
work leads to a change in food intake pattern, similar to data of Salgado-Delgado 
and colleagues (Salgado-Delgado et al., 2008). Second, we hypothesized that 
shift work rats would have an impaired glucose tolerance.
Methods
Animals and housing
Adult male Wistar rats (Harlan Netherlands BV, Horst, The Netherlands) weighing 
322.3 ± 1.6 g at start of the experiment were individually housed in Plexiglas 
cages in a climate-controlled room (21 °C ± 1) under a 12h:12h light-dark cycle. 
Rats were maintained ad lib on medium fat food (45% fat diet: Arie Blok 




throughout the study. Food intake and body weights were measured daily. 
Experiments were approved by the Institutional Animal Care and Use Committee 
of the University of Groningen. 
Surgery
All rats underwent surgery to place two bilateral jugular vein catheters (Steffens, 
1969). This allowed stress free glucose infusion and frequent blood sampling. 
Surgery was carried out under general isoflurane (2%) anesthesia. Rats were 
allowed to recover for at least 10 days prior the start of the experiments. 
Cannulas were checked and flushed at least once a week.
Shift work and Control work protocol
The rats were divided over two groups (Figure 1): a shift work group (n=7) and 
a control work group (n=8). Shift work rats were forced to be active for 8 hours 
during the light phase, i.e., their normal circadian resting phase. Control rats 
were forced to be active for 8h during the dark phase, i.e. the normal activity 
phase. Forced activity was accomplished by placing the rats in slowly 
rotating drums (diameter 40 cm), rotating at a constant speed of 0.4 m/min. 
Both experimental groups were subjected to this protocol for 14 consecutive days. 
Rats were habituated to the experimental conditions by placing them in the drums 
for 1-2h on 3 consecutive days before the onset of the experiments. 
Body weight and food intake
During the experimental period, body weight and food intake were measured daily. 
Food intake was measured both in the rotating drums (8h) and in the regular 
home cage (16h). In addition, on the baseline day and on day 13 of the experiment, 
food intake was measured during the 12h light and 12h dark phase.
Figure 1: The experimental protocol for the control work and shift work rats. Dark grey bars represent the 12h 
dark phase of the 24h light-dark cycle. The hatched light grey boxes with indicate the 8 hours when rats are 
placed into the slowly rotating drums and forced to be active.
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Intravenous glucose tolerance test and chemical analyses
To assess the effects of shift work on glucose regulation, rats were subjected 
to an intravenous glucose tolerance test (IVGTT) before (pre-experiment) and 
immediately after the experimental 14 day period (experiment). We decided 
to standardize the timing of the IVGTT at the end of the experiment relative to 
the work schedule and performed the test 17h after the last session of forced 
activity in the rotating drum for both the control work and shift work group. 
This means that the IVGTTs in the two treatment groups were performed 
at different circadian times. For shift work rats, IVGTTs were performed during 
the third and fourth hour of the light phase, whereas for control work rats 
IVGTTs were performed during the third and fourth hour of the dark phase. These 
circadian times were used for both the pre-experimental and experimental IVGTT. 
Food was removed 3 hours before the start of the IVGTT and 1 hour 
before the test rats were connected to the tubings for blood sampling and 
glucose infusion. During the IVGTT, a 15% glucose solution was infused for 
30 minutes at a rate of 0.1 ml/min. Blood samples for determination of blood 
glucose and plasma insulin levels were taken before, during and after the 
infusion of glucose at time points t = -10, -1, 5, 10, 15, 20, 25, 30, 35, 40 
and 50 min (t=0 was the start of the glucose infusion). All blood samples had 
a volume of 200 μl and were collected in EDTA (20 μL/ml blood) containing 
tubes on ice. The samples were centrifuged at 2600 g for 10 min and the 
plasma was stored at − 20 °C until analysis. Blood glucose levels were 
measured by Hoffman’s ferrocyanide method. Plasma levels of insulin were 
measured by Millipore Rat Insulin Radioimmunoassay and plasma levels 
of leptin were measured by Millipore Rat Leptin Radioimmunoassay 
(Linco Research, St. Charles, MO, USA). Plasma levels of corticosterone 
were measured by ImmuChem 125I Corticosterone Radioimmoassay 
(MP Biomedicals, Orangeburg, NY, USA).
Data analysis
All data in results section and figures are expressed as averages ± SEM. 
The effect of shift work on food intake and body weight was assessed by 
repeated measures analyses of variance (ANOVA). An effect of treatment on the 
percentage of food intake during the light and dark phase at baseline day (day 
0) and experimental day 13 was analyzed with one way ANOVA. To test for an 
effect of shift work on glucose homeostasis, we compared the glucose and insulin 
profiles during the pre-experimental IVGTT with the profiles after the 2-week 
experiment by repeated measures ANOVA. Since circadian time per se might 
affect insulin regulation and glucose clearance, glucose and insulin responses 
to an IVGTT were also tested by comparing shift work with control rats. For all 





Changes in body weight in the course of the experiment are shown in Figure 2. 
On average, during the 2-week work protocol from day 0 to 14, both the control 
work and shift work rats continued to gain weight (Repeated measures ANOVA; 
time effect: F(14,182)= 14.67, P<0.001). Although the shift work rats on average 
gained less weight than control work rats, this difference did not reach statistical 
significance (time * group interaction: F(14,182)= 1.52, P=0.11; group effect: 
F(1,13)= 1.62, P=0.23). However, at the end of the recovery week (day 21), 
the shift work rats had gained significantly less weight than control animals 
(One Way ANOVA: F(1,13)= 9.20, P<0.05). 
 Figure 3A represents total 24h food intake at baseline (day 0), during the 
experimental period (day 13) and after recovery (day 21). We specifically tested 
for group differences in overall food intake on day 13 and 21 to be at the end of 
the experimental protocol and recovery phase, when all rats presumably were 
adapted to the protocol and food intake was not confounded by the IVGTT on 
day 14. Overall, shift work rats ate slightly less than control work rats (Repeated 
measures ANOVA: group effect (F(1.13)= 6.29, P<0.05). However, there was no 
significant time effect or time x group interaction, suggesting these effects were 
independent of the shift work protocol per se. 
 Figure 3B shows the intake of food during the 8h sessions in the rotating drum 
for the same 3 days (day 0, 13 and 21). On all 3 days, shift work rats ate significant 
less compared to control rats (Repeated measures ANOVA: group effect (F(1,13)= 
67.36,P<0.001), but there was no time x group interaction. ANOVA also revealed 
an overall time effect (F(2,26)= 42.10, P<0.001) and posthoc tests showed a 
significant increase in food intake at experimental day 13 compared to baseline. 
At recovery day 21, food intake had returned to baseline. 
Figure 2:  Body weight gain in rats subjected to shift work (n=7) or control work (n=8). Data are shown for a 
baseline day (day 0), 14 experimental days and at the end of the recovery phase (day 21). Data are average 
values ± SEM. Asterisks indicate a significant difference between both groups (* P<0.05). 
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Figure 4 shows depicts food intake during the 8h in the rotating drums in more 
detail. In control rats, food intake during the daily 8h forced activity period did 
not change during the experimental days (nonlinear regression: R=0.16, One 
Way ANOVA: F(1,11)= 0.30, P>0.5). However, in shift work rats, food intake 
during the 8 hours in the drums gradually increased in the course of the 
14 experimental days (nonlinear regression: R=0.90, One WayANOVA: F(1,11)= 
47.40, P<0.0001).
Figure 3: Effects of shift work on food intake. (A) Total 24h food intake for control work and shift work rats 
on baseline day 0, experimental day 13, and recovery day 21. (B) Food intake during the forced activity 
phase in the rotating drum (8h) at the same days. Data are averages ± SEM. Asterisks indicate a significant 
different between both groups, a: significant difference in comparison to baseline; b:  significant difference in 




Percentage of food consumed during the total 12h light and 12h dark phase 
was calculated for baseline day 0 and experimental day 13 (Figure 5). 
During the baseline day, there was no difference between both groups. However, 
during the experimental day shift work rats had significantly higher food intake 
during the light phase (which included their 8h work phase), compared to 
control rats (One Way ANOVA: F(1,13)= 32.93, P<0.001) and compared to their 
own baseline (F(1,12)= 15.80, P<0.01). Control work rats on average showed 
a small increase in food intake during the dark phase of the experimental day 
(which included their 8h work phase) compared  to the dark phase of their own 
baseline day, but this did not reach statistical significance (F(1,14)= 3.99, P=0.07).
 Figure 6 depicts the glucose and insulin levels in response to an intravenous 
infusion of glucose, under pre-experimental baseline conditions and after 14 days 
of shift work or control work conditions. Intravenous infusion of glucose led to 
an increase in blood glucose and plasma insulin levels. After termination of the 
30-min glucose infusion, both glucose and insulin returned to pre-infusion levels. 
Fourteen days of shift work or control work conditions did not change the glucose 
and insulin responses to an IVGTT within each group. Shift work seems to lead 
to a small decrease in insulin response, but this effect did not reach statistical 
significance (Area under the curve: One Way ANOVA: F(1,12)= 2.20, P=0.16).
Figure 4: Food intake during the daily 8h of forced activity in the rotating drum for the shift work group (during 
light phase) and the control work group (during dark phase). Data are shown for a baseline day (day 0) and 
14 experimental days. Data are average ± SEM. See text for details on statistics. 
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As explained in the methods section, the time of day when the IVGTT 
was performed was different for shift work and control work rats. This difference 
in time of day is associated with different glucose and insulin profiles. 
Even under baseline conditions, the two experimental groups differed in 
their glucose and insulin responses (Repeated measures ANOVA: time x 
group interaction effect for the pre-experimental glucose profile: F(10,120)= 
10.37, P<0.001; pre-experimental insulin profile: F(10,120)= 6.73, P<0.001). 
This difference persisted during the experimental phase of the protocol 
(time x group interaction effect for the experimental glucose profile: 
F(10,120)= 5.49, P<0.01; experimental insulin profile: F(10,120)= 3.79, P<0.01).  
 Figure 7 depicts the area under the curve (AUC) of blood glucose and plasma 
insulin levels in response to the IVGTT. The AUC of blood glucose levels 
were significantly lower in shift work rats compared to control work rats during 
both the pre-experimental (One Way ANOVA: F(1,12)=22.43, P<0.001) and 
the experimental IVGTT (F(1,12)= 10.26, P<0.01). The AUC of plasma insulin 
levels were significantly higher in shift work rats compared to control work rats 
during the pre-experimental IVGTT (F(1,12)= 15.85, P<0.01) but this did not reach 
significance during the experimental IVGTT (F(1,12)= 3.54, P=0.08).
Figure 5: Percentage of food consumed during the light and dark phase on baseline day 0 and experimental 
day 13. For shift work rats, the 8h of activity was in the light phase, and for control work rats, the 8h of 
activity was in the dark phase. Data are averages ± SEM. a: significant difference in comparison to 
control rats, b: significant difference in comparison to baseline (P<0.05); # indicates a trend in comparison 





In this study we assessed the effects of a shift work protocol on food intake, body 
weight and glucose homeostasis in rats. Rats subjected to a 14-day shift work 
protocol with 8h of forced activity during their circadian resting phase displayed a 
gradual shift in food intake from their normal activity phase to their forced activity 
phase. Overall, total daily food intake did not differ between shift work rats and 
control work rats that were subjected to 8h of forced locomotion during their 
activity phase. We also investigated whether circadian disorganization affected 
glucose homeostasis during an IVGTT test, but no effect of shift work was found. 
In contrast to an earlier study on shift work (Salgado-Delgado et al., 2008), 
we did not find increased weight gain in shift work rats compared to control work 
rats. One explanation may be a difference in the protocol used. Although 
the amount and the timing of forced locomotion was similar in both studies, 
we used a continuous shift work protocol for 2 weeks, whereas Salgado-Delgado 
and colleagues alternated 5 days of shift work with undisturbed weekends 
and continued this protocol for 5 weeks. Thus, it might be that the length 
Figure 6: Blood glucose and plasma insulin levels in response to a 30-min intravenous glucose infusion under 
baseline conditions or after 14 days of shift work (graphs A and C, n=7) or control work (graphs B and D, n=8). 
Each graph presents the glucose or insulin profiles under pre-experimental baseline conditions (open circles) 
and after 14 days of shift work or control work (closed circles). The horizontal grey bars at the bottom of each 
graph represent the 30 min of 15% glucose infusion. Data are average values ± SEM. 
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of the protocol and the alternation between shift work and periods of rest are 
important factors to induce the body weight changes the authors found. 
Indeed, we recently found that the alternation between weeks of sleep restriction 
and weekends of sleep allowance prevents the attenuation of weight gain as 
seen during a continuous sleep restriction protocol (Barf et al., 2012).
Also, our finding of unaltered glucose tolerance in rats subjected to shift work 
may seem at odds with the loss of glucose rhythmicity reported in the study by 
Salgado-Delgado and colleagues (Salgado-Delgado et al., 2008). However, one 
should keep in mind that glucose rhythmicity and glucose homeostasis are not 
necessarily linked. 
 Importantly, while glucose tolerance was not affected by two weeks of shift work, 
in an earlier study we reported glucose intolerance after 8 days of restricted or 
disrupted sleep (Barf et al., 2010). It thus appears that the consequences of sleep 
disruption reported earlier are not mediated by circadian disruption but, rather, by 
changes in sleep per se (i.e., the amount of sleep or architecture of sleep).While 
rats on a shift work protocol may have an altered sleep-wake rhythm, total sleep 
time and sleep quality are not necessarily affected. Indeed, it has been shown 
in a human laboratory experiment that one week of shift work did not affect total 
sleep time or sleep quality afterwards (Lamond et al., 2003). Therefore it may be 
that changes in food intake patterns and changes in glucose homeostasis have 
independent underlying mechanisms, which are differently affected by shift work 
or sleep disruption.
 Insulin and glucose responses to the IVGTT in this experiment were quite 
different for shift work and control work rats. This difference was already present 
under baseline conditions before the start of the experimental protocol and is a 
consequence of the fact that the IVGTTs were performed at different times of day. 
Figure 7: Area under the curve (AUC) of blood glucose (A) and plasma insulin (B) levels in response to 
a 30-min intravenous glucose infusion under pre-experimental conditions or after 14 experimental days. 
Data are average values ± SEM. Asterisks indicate a significant difference between both groups (* P<0.01); 




The IVGTT was performed 17h after the last forced activity period in the rotating 
drum for both groups. For shift rats, the IVGTT took place in the 4th hour of the 
light phase, whereas for control rats the IVGTT took place in the 4th hour of the 
dark phase. Literature has reported that glucose homeostasis varies across the 
24h cycle (Kalsbeek et al., 2010;La Fleur et al., 2001). During the inactive phase, 
the body is less glucose tolerant and less insulin sensitive, resulting in increased 
insulin levels in response to an IVGTT. During the active phase, more glucose 
is needed for daily activities, leading to increased glucose levels and decreased 
insulin levels. This is indeed also visible in our data.
 In conclusion, our current data do not support the hypothesis that shift work leads 
to disturbed metabolic regulation and glucose intolerance. Since our previous data 
demonstrated clear effects of sleep restriction on glucose homeostasis (Barf et 
al., 2010), it might be that the circadian organization is not the crucial factor, but 
disturbed sleep is.
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Rodent models for sleep restriction have good face validity when examining 
food intake and related regulatory metabolic hormones. However, in contrast to 
epidemiological studies where sleep restriction is associated with body weight 
gain, sleep restricted rats show a decrease in body weight. This difference 
with the human situation might be caused by the alternation between periods 
of sleep restriction and sleep allowance that often occurs in real life. 
Therefore we assessed the metabolic consequences of a chronic sleep 
restriction protocol that modeled working weeks with restricted sleep time 
alternated by weekends with sleep allowance. We hypothesized that this 
protocol could lead to body weight gain. Male Wistar rats were divided over three 
groups: sleep restriction (SR), forced activity control (FA) and home cage control 
(HC). SR rats were subjected to chronic sleep restriction by keeping them 
awake for 20h per day in slowly rotating drums. To model the human condition, 
rats were subjected to a 4-week protocol with each week consisting of a 5-day 
period of sleep restriction followed by a 2-day period of sleep allowance. 
During the first experimental week, SR caused a clear attenuation of growth. 
In subsequent weeks, two important processes occurred: 1) a remarkable 
increase in food intake during SR days, 2) an increase in weight gain during 
the weekends of sleep allowance, even though food intake during those 
days was comparable to controls. In conclusion, our data revealed that the 
alternation between periods of sleep restriction and sleep allowance lead to 
complex changes in food intake and body weight, that prevented the weight 
loss normally seen in continuous sleep restricted rats. Therefore this 
“week-weekend” protocol may be a better model to study the metabolic 
consequences of restricted sleep.
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Introduction
Sleep loss is a common problem in our modern society. Both epidemiological and 
clinical data suggest that disturbed sleep may contribute to the development of 
various diseases, e.g. obesity and type 2 diabetes (Cappuccio et al., 2008;Chaput 
et al., 2006;Chaput et al., 2007;Gottlieb et al., 2005;Spiegel, 2008;Spiegel et al., 
2009). Restricted sleep also leads to alterations in food intake and its regulatory 
hormones, particularly an increased appetite and preference for fat, together 
with increased levels of ghrelin and decreased levels of leptin (Spiegel et al., 
2004;Taheri et al., 2004).
 There are several rodent models for sleep deprivation; for example, the disk-over-
water method (Everson and Crowley, 2004;Rechtschaffen and Bergmann, 1995), 
the inverted flowerpot (or platform) paradigm (Hipolide et al., 2006;Mendelson et 
al., 1974), and the slowly rotating drum paradigm (Barf et al., 2010;Novati et al., 
2008;Roman et al., 2005). In general, the changes in blood hormone levels and 
food intake in these models are similar to the findings in humans. Sleep deprivation 
decreased plasma insulin (Hipolide et al., 2006) and leptin levels (Everson and 
Crowley, 2004) and increased food intake was observed in some (Everson and 
Crowley, 2004;Hipolide et al., 2006;Koban and Stewart, 2006;Koban et al., 
2008;Rechtschaffen and Bergmann, 2002;Rechtschaffen and Bergmann, 1995) 
but not all studies (Barf et al., 2010). However, the most consistent finding among 
these studies is that sleep deprived rats lose weight (Barf et al., 2010;Everson 
and Crowley, 2004;Hipolide et al., 2006;Koban and Stewart, 2006;Koban et al., 
2008;Rechtschaffen and Bergmann, 2002;Rechtschaffen and Bergmann, 1995), 
which is in contrast to the human finding where a lack of sleep generally is 
associated with weight gain (Chaput et al., 2006;Knutson and Van Cauter, 2008). 
 The reason for this difference between rats and humans is unknown. There is 
some indirect evidence that the differences in weight gain vs. weight loss might 
be related to the nature of the sleep restriction protocol. Sleep loss in humans is 
in general an alternation between sleep restriction during the week and 
recuperation from sleep loss in the weekend (Valdez et al., 1996). In contrast, 
experimental studies in rats often consist of a continuous period of sleep restriction 
without periods of recovery. Indirect evidence comes from a shiftwork study by 
Salgado-Delgado and colleagues who subjected rats to a protocol consisting of 
alternating 5-day periods of shift work and 2-day period of undisturbed sleep-wake 
rhythms, and indeed they found a clear increase in body weight (Salgado-Delgado 
et al., 2008;Salgado-Delgado et al., 2010). 
 Based on these studies, we hypothesized that an alternation between periods of 
sleep restriction and periods of sleep allowance is critical for the induction of body 
weight gain in a sleep restriction paradigm. Therefore we evaluated the behavioral 
and metabolic consequences of a sleep restriction protocol consisting of 5 days 
of sleep restriction alternated by 2 days in which the rats were allowed to recover. 
This protocol was continued for four weeks. We hypothesize that the 2 days of 







Male Wistar rats (weight 302.1 ± 1.2 g at start of the experiment, derived from 
Harlan Netherlands BV, Horst, The Netherlands) were individually housed in 
Plexiglas cages in a climate-controlled room (21 °C ± 1) under a 12h: 12h light-dark 
cycle (lights on at 1:00 PM). Animals were maintained ad lib on medium fat food 
(45 % fat: Arie Blok Diervoeding B.V., Woerden, The Netherlands), which mimics 
the human diet and is the standard diet in our previous studies on metabolism 
(Barf et al., 2010). Water was available ad lib throughout the study. Food intake 
and body weights were measured daily. Experiments were approved by the Ethical 
Committee of Animal Experiments of the University of Groningen. 
Chronic sleep restriction and forced activity 
The rats were assigned to one of three groups. The first group was subjected to 
chronic sleep restriction (SR, n-12). SR was achieved by placing the rats in slowly 
rotating drums, according to previously described methods (Meerlo et al., 2002). 
Briefly, rats were allowed to sleep in their home cage for only 4 hours per day at 
the beginning of the light phase. During the remaining 20 hours, the rats were 
kept awake by placing them in slowly rotating drums (diameter 40cm), rotating 
at a constant speed of 0.4 m/min (Barf et al., 2010;Novati et al., 2008;Roman 
et al., 2005). To model the human condition with alternating working weeks and 
weekends of rest, rats were subjected to a 4-week schedule with each week 
consisting of a 5-day “working week” (5 consecutive days with SR or FA) followed 
by a 2-day “weekend” (2 days of uninterrupted sleep allowance in the home cage). 
The second group was a forced activity control group (FA: n=7). The FA rats 
served as controls for the amount of exercise and walked the same distance as the 
SR rats in 2 hours at the end of the dark phase (wheels by TSE, Bad Homburg, 
Germany). Thus, the FA group walked the same distance but was not sleep 
restricted. Both the SR and FA groups were forced to walk 480m/day during 
the “working week”, which is approximately 10-20% of the distance rats cover 
voluntarily (Scheurink et al., 1999). The rats of the SR and FA groups had unlimited 
access to food and water inside the drums. The third group of rats consisted 
of home cage controls (HC, n=5) which remained in their home cage throughout 
the experiment.
Blood samples and chemical analysis
To assess the effects of sleep restriction on metabolic hormones, blood samples 
were taken in week 1 and week 4 of the experiment for analysis of glucose, 
insulin, leptin and corticosterone. Samples were taken immediately after the 5-day 
working week (working week: day 5 and day 26) at the beginning of the lights 
phase (ZT0) and after four hours of rest (ZT4). Another blood sample was taken 
after two days of rest (weekend: day 7 and day 28) during the 4th hour of the 
light phase (ZT4). Blood samples of approximately 0.5 ml were drawn from the 
tail (Fluttert et al., 2000;Meerlo et al., 2002) and collected in pre-cooled cups 
86 87
Increased food intake and changes in metabolic hormones in response to chronic sleep 
restriction alternated with short periods of  sleep allowance
containing EDTA. Afterwards, the samples were centrifuged at 4 °C for 10 min at 
2600 g, and the plasma was stored at −20 °C until further analysis. Blood glucose 
was measured by Hoffman’s ferrocyanide method and plasma levels of insulin, 
leptin and corticosterone were measured by Millipore Rat Radioimmunoassays 
(Linco Research, St Charles, MO, USA).
Indirect calorimetry
At the first day of the final weekend of sleep allowance (day 26), immediately 
after the last SR/FA period, rats were transferred to respirometric chambers 
(45×25×30 cm) to determine oxygen consumption (V·O2, l/h) and carbon dioxide 
production (V·CO2, l/h). Oxygen and carbon dioxide concentration of dried inlet 
and outlet air (drier: molecular sieve 3 Å, Merck) from each chamber was measured 
with a paramagnetic oxygen analyzer (Servomex Xentra 4100) and carbon 
dioxide by an infrared gas analyzer (Servomex 1440). The system recorded the 
differentials in oxygen and carbon dioxide between dried reference air and dried 
air from the metabolic chambers. Flow rate of inlet air (60 l/h) was measured 
with a mass-flow controller (Type 5850 Brooks). Samples were collected every 
10 min (allowing optimal air mixing) for each animal and automatically stored 
on a computer. Behavioural activity of the animals was recorded with calibrated 
passive infrared detectors (PIR: Optex Wonderex FX-35; OPTEX (Europe) LTD., 
Berkshire, UK). Animals were measured at an ambient temperature of 21 °C and 
food and water were provided ad libitum over the whole period. Energy expenditure 
(kJ) was calculated using the following equation of Ferrannini (Ferrannini, 1988):
EE=(16.18×VO2×0.001) + (5.02×VCO2×0.001). 
During the 24 hours in the indirect calorimetry, fecal pellets were collected. 
The rotating drum system to sleep restrict rats could not be combined with 
the respirometry system and therefore it was not possible to measure oxygen 
consumption during the working weeks of SR/FA.
Statistical analysis
The data in the figures and text are expressed as averages ± SEM. The effects 
of the sleep restriction and forced activity protocols on food intake, body weight 
and blood hormone levels were tested by repeated measures analysis of variance 
(ANOVA) with between-subjects factor ‘treatment’ (SR, FA, or HC) and within-
subjects factor ‘time’ (day of the experimental protocol). Indirect calorimetry data, 
body weight gain, average daily food intake and feces weight was tested by One 
Way ANOVA with factor ‘treatment’ (SR, FA, or HC). When appropriate, a posthoc 
Tukey test was applied to establish differences between the three groups (controls, 





Daily body weight and food intake are shown in Figure 1. Both body weight and 
food intake differed significantly over time (Repeated Measures ANOVA effect of 
time for body weight: F(32,672)= 411.73, P<0.001; food intake: F(30,600)= 7.57, 
P<0.001). The increase in body weight was significantly attenuated in SR rats 
compared to home cage controls (Repeated Measures ANOVA treatment x time 
interaction: F(64,672)= 3.26, P< 0.001; posthoc Tukey test: SR vs. HC: P<0.05). 
Food intake of SR rats increased after the first recovery weekend compared to 
both FA and HC rats (Repeated Measures ANOVA treatment x time interaction: 
F(60,600)= 6.48, P<0.001; posthoc Tukey test: experimental week 2-4: SR vs. 
FA and SR vs. HC: P<0.05). 
 In Figure 2, data are averaged for week 2-4, when the effects of sleep restriction 
and patterns of body weight and daily food intake had stabilized (average body 
weight gain or food intake divided by the amount of days (7, 5 or 2 days)). SR rats 
had a slight reduction in weight gain during the 5-day working weeks (F(2,21)=3.48, 
P<0.05, posthoc Tukey test: SR vs. HC: P<0.05). Both SR and FA rats showed 
an increase in their body weight gain during the weekends of rest (F(2,21)= 8.38, 
P<0.01, posthoc Tukey test: SR vs. HC and FA vs. HC: P<0.05). The total body 
weight gain was not different between groups.
 During week 2-4, average daily food intake was significantly increased during 
the 5-day sleep restriction periods (One Way ANOVA: F(2,21)= 43.26, P<0.001, 
posthoc Tukey test: SR vs. FA and SR vs. HC: P<0.001) but returned to control 
levels during the 2-day weekends of rest (F(2,21)= 1.65, P>0.1). For the week 
totals, including both the working week and recovery weekend, average daily food 
intake remained significantly increased for SR rats (F(2,21)= 23.38, P<0.001, 
posthoc Tukey test: SR vs. HC and SR vs. FA: P<0.001).
 Glucose, insulin, leptin and corticosterone levels (Table 1) were measured 
at the end of the first and fourth working week, immediately after the rats had 
returned to their home cage at the beginning of the light phase (ZT0), after 4 
hours of rest (ZT4) and after 2 days rest (weekend: ZT4). No changes over time 
or between groups were found in glucose levels. For insulin levels, Repeated 
Measures ANOVA revealed a significant time effect (F(5,105)= 2.60, P<0.05) 
and a significant treatment x time interaction (F(10,105)= 2.26, P<0.05). Posthoc 
Tukey revealed decreased insulin levels in SR and FA rats as compared to HC rats 
at the end of working week 1 and 4. Insulin levels returned to control values after 
2 days of rest. 
 Leptin levels showed a similar pattern. Repeated Measures ANOVA revealed a 
significant time effect (F(5,105)= 6.48, P<0.001) and a nearly significant treatment 
x time interaction (F(10,105)= 1.74, P=0.08). Posthoc Tukey revealed decreased 
leptin levels after both 1 and 4 weeks of SR but not FA, which are back to control 
levels after 2 days of rest. 
 Corticosterone levels showed a significant time effect (F(5,105)= 26.00, P<0.001) 
and a significant treatment x time interaction (F(10,105)= 10.77, P<0.001). At the 
end of the first 5-day working week, immediately after the last 2h forced locomotion 
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session, FA rats had significantly increased corticosterone levels (posthoc 
Tukey test, FA vs. HC and FA vs. SR: P<0.05), which had returned to control 
levels after 4 hours of rest. The same pattern was visible after 4 weeks of FA 
(Posthoc Tukey test, FA vs. HC and FA vs. SR: P<0.05), although the increase 
in corticosterone levels after FA was less pronounced compared to week 1 
(Paired t-test: t=4.11, P<0.01). 
Figure 1: Daily food intake (A) and body weight (B) during baseline, 4 experimental weeks and 4 weekends 
of sleep allowance for SR (n=12), FA (n=7) and HC (n=5) rats. The grey bars represent the 5-day weeks of 
SR or FA. Data are average values ± SEM. Significant differences (P<0.05): * SR vs. both control groups; # 




Figure 2: Average food intake and body weight gain per day during experimental week 2-4 for SR (n=12), 
FA (n=7) and HC (n=5) rats. Averages are shown per total 7 days, per experimental week (5 days) and per 
weekend of sleep allowance (2 days). Data are average values ± SEM. * P<0.05. 
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Data derived from indirect calorimetry on the first recovery day after the fourth 
working week is shown in Figure 3. Daily energy expenditure did not differ between 
groups during the light phase, dark phase and total 24 hours. The respiratory 
quotient (RQ: CO2 production/O2 consumption) during the 24h respirometry 
measurement was significantly lower in SR rats as compared to control rats 
(SR: 0.92 ± 0.01; FA: 0.95 ± 0.01; HC: 0.95 ± 0.01; F(2,21)= 3.85, P<0.05; 
Posthoc Tukey test: SR vs. FA and SR vs. HC: P<0.05). Levels of activity were 
significantly decreased for SR rats during the light phase (F(2,15)= 7.47, P<0.01, 
posthoc Tukey test, SR vs. FA: P<0.05). Total 24h activity levels tended to 
be lower but this did not reach statistical significance (F(2,15)= 3.11, P=0.07). 
Furthermore, feces were weighed for all rats. SR rats had significantly less feces 
during the first day of sleep allowance in the indirect calorimetry (SR: 3.8 ± 0.2g; 
FA: 4.8 ± 0.3g; HC: 4.7 ± 0.3g; One Way ANOVA: F(2,20)= 4.79, P<0.05, posthoc 
Tukey test, SR vs. FA: P<0.05).
Working week 1 Weekend 1 Working week 4 Weekend 4
ZT0 ZT4 ZT4 ZT0 ZT4 ZT4
Glucose (mM)
HC 5.9 ± 0.2 6.1 ± 0.1 6.2 ± 0.2 5.9 ± 0.1 6.1 ± 0.1 6.2 ± 0.3
FA 6.0 ± 0.1 5.8 ± 0.1 6.1 ± 0.1 6.0 ± 0.2 5.8 ± 0.2 6.0 ± 0.1
SR 5.9 ± 0.1 5.7 ± 0.1 6.0 ± 0.1 6.1 ± 0.2 5.9 ± 0.1 6.1 ± 0.1
Insulin (ng/ml)
HC 4.8 ± 1.1 4.5 ± 0.5 4.4 ± 0.9 4.9 ± 0.9 5.2 ± 0.7 3.7 ± 0.5
FA 2.3 ± 0.2* 3.4 ± 0.5 3.8 ± 0.5 2.6 ± 0.6* 3.1 ± 0.4* 3.4 ± 0.4
SR 2.7 ± 0.3* 2.6 ± 0.3* 3.7 ± 0.4 2.9 ± 0.2* 3.9 ± 0.4 3.3 ± 0.3
Leptin (ng/ml)
HC 16.3 ± 3.7 11.9 ± 1.1 11.6 ± 1.7 17.6 ± 2.7 15.3 ± 2.8 13.5 ± 2.4
FA 10.7 ± 3.1 8.3 ± 2.0 10.8 ± 2.3 10.7 ± 2.7 10.0 ± 3.2 12.3 ± 4.5
SR 8.3 ± 0.9* 6.3 ± 0.6* 8.7 ± 0.8 10.2 ± 0.7* 9.3 ± 0.9 10.3 ± 1.3
CORT (ng/ml)
HC 19.2 ± 2.1 16.2 ± 5.0 31.7 ± 9.7 11.3 ± 2.5 7.7 ± 2.3 26.8 ± 14.1
FA 376.6 ± 71.9* 11.7 ± 1.3 18.0 ± 2.2 158.9 ± 27.5* 4.9 ± 1.3 14.4 ± 1.7
SR 132.4 ± 38.7† 11.2 ± 0.7 21.3 ± 2.3 77.8 ± 20.5† 10.3 ± 1.4 27.8 ± 5.3
Blood samples were taken during the 1st and 4th week of the experiment. For both weeks, samples were 
taken immediately after 5 experimental days (working week) at the beginning of the light phase (ZT0) and 
after 4 hours of rest (ZT4); another sample was taken after 2 days of rest (weekend) during the 4th hour of 
the light phase (ZT4). Data are average values ± SEM (SR: n=12, FA n=7 and HC n=5). Values are means ± 
SEM. Significant differences (P<0.05): * compared to HC, † compared to FA.






The most striking result of the present study is the significant increase in food 
intake, which appeared after the first weekend of sleep allowance. The first period 
of sleep restriction was similar to our previously published data, in which 8 days 
of sleep restriction led to unchanged food intake, but a clear weight loss (Barf et 
al., 2010). After the first weekend of sleep allowance, rats become hyperphagic, 
preventing further weight loss. A second interesting finding is that the rats have 
normal food intake during the weekends of sleep allowance, but significant weight 
gain in this period. Together, these data support the hypothesis that an alternation 
between periods of sleep restriction and sleep allowance can prevent the weight 
loss normally seen in sleep restricted rats. Therefore this “week-weekend” protocol 
has increased face validity in comparison to our earlier sleep restriction protocol 
that did not include the intervening periods of sleep allowance.
 It is important to note that our experimental rats had increase body weight gain 
only during the weekends of sleep allowance as compared to the home cage 
controls, but not during the working weeks. Overall, even at the end of the 4-week 
protocol, the SR rats were still slightly lighter than controls. Even though our 
current protocol of sleep restriction alternated with weekends of sleep allowance 
attenuates the weight loss seen with continuous sleep restriction in literature, rats 
still do not become overweight or obese. This suggests that sleep restriction per 
se is not sufficient to produce obesity in rats.
 The present experiment was indirectly based on a study by Salgado-Delgado 
and colleagues, who showed that subjecting rats to a shift work protocol with 
forced locomotion during the normal rest phase led to a significant increase in body 
weight as compared to controls (Salgado-Delgado et al., 2008;Salgado-Delgado 
et al., 2010). In their study, shift working weeks were alternated with weekends of 
undisturbed rest, which may have been a crucial factor in the reported body weight 
increase. The reason why their shift work protocol resulted in a net increase 
in body weight above control levels while our current protocol only attenuated 
the body weight loss seen in previous studies may lie in the methodological 
differences. While both models interfered with sleep by subjecting rats to forced 
activity, the Salgado-Delgado shift work protocol specifically disrupted circadian 
organization whereas our model only aimed to shorten sleep. It may thus be that 
disrupting circadian organization has additional effects beyond sleep disruption 
that contribute to the body weight increase. 
 In our present study, SR rats lost only weight during the first week of the 
protocol, similar to what was reported before (Barf et al., 2010). This decrease in 
weight may be a result of increased energy expenditure associated with prolonged 
wakefulness and increased activity. Indeed several studies have shown increased 
energy expenditure during sleep deprivation (Bergmann et al., 1989;Caron and 
Stephenson, 2010;Hipolide et al., 2006;Koban and Swinson, 2005) and one 
explanation for this change in energy expenditure, and in turn the attenuation 
of body weight gain, could be an increase in the gene expression of uncoupling 
protein-1 (UCP-1) in the brown adipose tissue (BAT). BAT is known for its 
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regulatory non-shivering thermogenesis in rodents and heat production is 
mediated by UCP-1 (Cannon and Nedergaard, 2004). Indeed, Koban and Swinson 
have demonstrated that during sleep deprivation UCP-1 is increased over time, 
together with an increase in O2 consumption (Koban and Swinson, 2005). 
Thus, in our study it might be that the 5 days of sleep restriction leads to increased 
energy expenditure and increased UCP-1, whereas during the weekends of 
sleep allowance both return to baseline. 
 During the second week of the protocol, rats started compensating for the 
presumed increased energy expenditure associated with sleep restriction 
by increasing their food intake. These changes in food intake may be related 
to changes in hypothalamic neuropeptides such as orexin and neuropeptide Y. 
Figure 3: Total energy expenditure and average cage activity (PIR) measured with indirect calorimetry during 
the first day of sleep allowance after week 4 for SR (n=12), FA (n=7) and HC (n=5) rats. Data are average 




Orexin is involved in the regulation of both the sleep/wake cycle and food intake 
regulation (Sakurai, 1999;Sakurai, 2002). Some studies have demonstrated 
that REM sleep deprivation increases orexin levels in the CSF and orexin 
immunoreactivity in the lateral hypothalamic area (Galvao et al., 2009;Pedrazzoli 
et al., 2004). Furthermore, orexin neurons project densely to the arcuate nucleus, 
which is known for its involvement in food intake regulation (Nambu et al., 1999). 
Indeed, REM sleep deprivation leads to significant increases in neuropeptide Y 
mRNA levels (Koban et al., 2006;Koban et al., 2008). Recently, it has also been 
demonstrated that sleep deprivation increases orexin mRNA levels which in turn 
activate the arcuate neuropeptide Y neurons that could lead to hyperphagia 
(Martins et al., 2010). Thus, it might be that in our experiment, sleep restriction after 
the first weekend of sleep allowance leads to increased orexin and neuropeptide 
Y levels in the brain, causing the rats to increase their food intake only during 
periods of sleep restriction. During the weekends rats are allowed to sleep, which 
might lead to a decrease in central orexin levels, and in turn cause food intake to 
return to baseline values. Future experiments should be performed to verify this.
 The data in figure 2 reveal that the sleep restricted rats are only hyperphagic 
during the periods of sleep restriction, whereas the weight gain only occurs 
during the periods of sleep allowance when the rats are not hyperphagic. 
Why the rats do not gain weight when they are hyperphagic during the periods of 
sleep restriction may be due to a number of factors. One may argue that the exercise 
protocol of 480 m/day may have increased the energy expenditure of the rats. 
However, the FA control rats walked the same distance per day, did not increase 
their food intake during these periods of forced locomotion and did not lose 
body weight. Nevertheless, it might be that the sleep restriction protocol itself 
has effects on the energy expenditure beyond the increase in locomotor activity. 
Due to methodological limitations we were not able to measure energy expenditure 
during the 5-day periods of SR, therefore we can only speculate that energy 
expenditure most probably is increased during SR, similar to what has been 
published before (Bergmann et al., 1989;Caron and Stephenson, 2010;Hipolide et 
al., 2006;Koban and Swinson, 2005). 
 The finding that SR rats gain weight when they are not hyperphagic during 
the periods of sleep allowance can be interpreted in relationship to the effects 
of sleep restriction on sleep time and intensity. It is tenable to assume that 
recovery from sleep restriction is associated with increased sleep time and sleep 
intensity, as others have demonstrated that rats do sleep longer and deeper 
after sleep acute sleep deprivation and chronic sleep restriction (Leemburg et 
al., 2010;Machado et al., 2005). However, the data in figure 4 demonstrate that 
energy expenditure is not different between groups during these periods of sleep 
allowance, even though total activity is decreased. The question of how SR 
rats grow faster during the fourth weekend of sleep allowance, despite similar 
food intake and overall energy expenditure in the different groups, remains. 
One explanation might be increased food efficiency. One may argue that increased 
energy absorption in the intestinal tract can be used for recovery, storage and 
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thus weight gain. This is indirectly supported by the fact that the feces weight 
of SR rats is decreased during weekends of sleep allowance compared to the 
control groups. This decrease indicates that, even though energy intake and 
energy expenditure are similar compared to controls, the food efficiency might be 
higher in SR rats during a period of sleep allowance, leading to increased body 
weight gain. 
 Although SR rats increase their food intake from week 2 onwards, leptin 
and insulin levels were still decreased at the end of the fourth working week, 
which is in agreement with the fact that these rats still had a slightly lower 
weight than control rats. These hormones reflect the nutritional status of the rat. 
However, both leptin and insulin are also satiety hormones, which could also be 
another explanation for the increase in food intake during the periods of sleep 
restriction. The corticosterone levels of FA rats, immediately after the experimental 
period, were strongly increased. For SR rats this did not reach significance. 
This increase in corticosterone for FA rats is in agreement with the notion that 
corticosterone may in part reflect and support behavioral activity (Koolhaas et al., 
2011). For instance, Koolhaas and colleagues have demonstrated that stressful 
events but also pleasurable events, such as a sexual experience, can lead to similar 
increases in corticosterone. Therefore, an increase in corticosterone is associated 
with behavior and in our case, forced locomotion. The fact that corticosterone 
levels rapidly returned to baseline during 4 hours of sleep allowance suggests 
that our sleep restriction protocol is not a chronic stressor.
Perspectives and Significance
Our data revealed that the alternation between periods of sleep restriction and 
periods of sleep allowance lead to complex changes in food intake and body 
weight that prevented the negative energy balance normally seen during 
continuous sleep restriction in rat studies. Although the discrepancy between 
epidemiological studies and rat studies remains, the alternation between 
periods of sleep loss and periods of sleep allowance seems to be a crucial factor 
and an important addition to the sleep deprivation literature. 
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The serotonergic system plays an important role in the regulation of mood. 
Experimental studies in rats show that chronic sleep restriction leads to altered 
serotonergic function, including a desensitization of the serotonin 1A receptor 
system. Such changes may in part be an indirect consequence of changes 
in body weight. To determine whether a medium fat (MF) diet could protect 
against these effects of sleep restriction by preventing the decrease in body weight, 
we subjected rats to a schedule of chronic sleep restriction during which half 
of the sleep restricted rats were maintained on a MF diet. To study the serotonin 
1A receptor sensitivity, we measured body temperature and endocrine 
responses to injections with the serotonin 1A agonist 8-OHDPAT after 8 days 
of sleep restriction. We found that a MF diet strongly attenuated the drop in 
body weight normally seen in sleep restricted rats on Chow. However, this did 
not prevent desensitization of the serotonin 1A system. Sleep restricted rats on 
both diets showed a similarly blunted body temperature response and pituitary 
ACTH response upon serotonin 1A stimulation. Insulin and leptin levels were 
equally decreased in both sleep restricted groups despite differences in body 
weight. These results indicate that changes in serotonin 1A receptor sensitivity 
following sleep restriction are not dependent on diet and body weight changes. 
The desensitization might be the result of altered regulation of physiological 
and endocrine factors and it may in part be the consequence of a cumulative effect 
of sleep loss directly acting on the brain. 
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Introduction
Restricted and disrupted sleep is a common problem in our Western society. 
Epidemiological and clinical studies suggest that chronically disrupted sleep may 
contribute to the development of various diseases, including mood disorders such 
as depression (Breslau et al., 1996;Chang et al., 1997;Ford and Kamerow, 1989). 
Impairment of serotonergic neurotransmission might be one of the pathways 
through which insufficient sleep contributes to the onset of depressive symptoms. 
This idea is supported by experimental studies in laboratory rats showing that 
chronic sleep restriction causes a gradually developing desensitization of the 
serotonin 1A receptor system and an attenuation of 1A-mediated functions 
(Novati et al., 2008;Roman et al., 2005;Roman et al., 2006). Yet, it remains an 
important question what aspect of sleep disturbance is causing these alterations 
in serotonergic function. 
 One factor that deserves attention in this context is metabolism. Controlled 
studies in humans have shown that sleep restriction is associated with changes 
in metabolic regulation, alterations in glucose homeostasis, and increases 
in appetite (Donga et al., 2010;Spiegel et al., 2002;Spiegel et al., 2004). 
Also, numerous studies on prolonged sleep deprivation in rodents have reported 
increased food intake and reduced body weight (e.g. Everson, 1995;Hipolide et 
al., 2006;Rechtschaffen and Bergmann, 1995). In recent studies, we focused on 
the metabolic consequences of sleep restriction in our rat model. Sleep restriction 
for 8 days resulted in weight loss and reduced insulin responses, accompanied 
with glucose intolerance and hyperglycemia (Barf et al., 2010).  
 Based on the data above, one could argue that changes in serotonergic 
neurotransmission resulting from chronically restricted sleep might be secondary 
to the effects on energy metabolism and body weight. Indeed, literature shows 
that weight loss affects serotonin levels (Bailer et al., 2005;Brewerton, 
1995;Haleem, 2009;Kaye et al., 2005) and a decrease in body weight due to food 
restriction is associated with a desensitization of the serotonin 1A receptor in rats 
(Li and France, 2008;Li et al., 2009). Furthermore, partially preventing a decrease 
in body weight in socially stressed rats by providing them with a fat food diet also 
prevents the stress-induced serononin-1A desensitization (Buwalda et al., 2001). 
 In the present study we investigated whether sleep restriction-induced changes 
in serotonergic signaling might be a consequence of changes in metabolism 
and body weight and we assessed if a fat food diet could protect against these 
effects of insufficient sleep. A study was performed in which half of the sleep 
restricted rats received a medium fat (MF) diet with a higher caloric density 
compared to standard Chow food. We hypothesized that the MF diet during 
the sleep restriction protocol would prevent at least partly the decrease in body 
weight compared to rats on standard Chow. To assess whether this would also 
prevent the changes in serotonin 1A receptor sensitivity, we measured body 
temperature and endocrine responses to injections with the serotonin 1A receptor 
agonist (±)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide (8-OHDPAT) 






Male Wistar rats (weight ± 320g; Harlan Netherlands BV, Horst, The Netherlands) 
were individually housed in Plexiglas cages in a climate-controlled room (21 °C 
± 1) under a 12h:12h light-dark cycle (lights on at 10:00h). Water and food were 
available ad libitum throughout the study. Different experimental groups were fed 
with standard Chow food or MF food (respectively, 14% vs. 45.0% fat, 63% vs. 30% 
carbohydrates and 23% vs. 25% proteins; Arie Blok Diervoeding B.V., Woerden, 
The Netherlands). Ten days prior to the onset of the experiments animals were 
introduced to the MF diet. Body weight and food intake were measured daily. 
Energy intake was calculated on the basis of the caloric density for both food 
types (Chow: 3.7 kCal/g; MF: 4.8 kCal/g). Experiments were approved by the 
Ethical Committee of Animal Experiments of the University of Groningen. 
Chronic sleep restriction
Rats were subjected to chronic sleep restriction according to a previously published 
method (Barf et al., 2010;Novati et al., 2008;Roman et al., 2005). Sleep restriction 
groups were allowed to sleep in their home cage for 4 hours per day at the 
beginning of the light phase, i.e., their normal resting phase. During the remaining 
20 hours, rats were kept awake by placing them in drums rotating at a constant 
speed of 0.4 m/min. Rats were subjected to this schedule of sleep restriction 
for 8 days during which they had free access to food and water inside the drums. 
All rats were habituated to the experimental conditions by placing them in the 
drums for 1-2h on 3 consecutive days before the onset of the sleep restriction 
protocol. Control rats were left undisturbed in their home cage throughout the 
experiment.
Experiment 1: Radio telemetry and serotonin 1A mediated temperature 
responses 
In the first experiment we assessed the effects of MF food during the sleep restriction 
protocol on the sensitivity of the serotonin 1A receptor by measuring the acute 
hypothermic response to an 8-OHDPAT challenge (Roman et al., 2005;Roman et 
al., 2006). All rats were equipped with radio telemetry transmitters in the abdominal 
cavity to measure body temperature (model TA10TA-F40; Data Sciences, St. Paul, 
MN, USA). Surgeries were carried out under general 2% isoflurane inhalation 
anesthesia. The transmitters measured core body temperature and transformed 
temperature values into frequency coded radio signals. These radio signals 
were relayed to a PC by receivers placed underneath the home cages (model 
RPC-1; Data Sciences, St. Paul, MN, USA). Body temperature was sampled 
for 10 seconds every 10 minutes and processed with Dataquest LabproTM 
(Data Sciences). After 10 days of recovery from surgery, rats were divided over 
three groups (n=8 in each group): home cage control on standard Chow food 
(Control-Chow), sleep restriction on standard Chow food (SR-Chow), and sleep 
restriction on medium fat food (SR-MF). In this first experiment we did not include 
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a control group on MF food since previous studies indicated that fat food per se 
does not affect serotonin 1A mediated body temperature responses (Buwalda et 
al., 2001). After the last sleep restriction session on day 8, during the fourth hour 
of the light phase, all rats received a subcutaneous injection of the serotonin 1A 
receptor agonist 8-OHDPAT (Sigma, St. Louis, MO, USA) at a concentration of 
0.25 mg/kg body weight (Roman et al., 2005;Roman et al., 2006).  
Experiment 2: Blood sampling and serotonin 1A mediated pituitary ACTH 
response
In the second experiment we studied the effects of MF food and sleep restriction 
on the sensitivity of the serotonin 1A system by measuring the pituitary ACTH 
response to an 8-OHDPAT challenge (Novati et al., 2008). Serotonin 1A receptors 
at the level of both the hypothalamic paraventricular nucleus and the pituitary play 
an important role in regulating ACTH release (Dinan, 1996;Fuller, 1992). All rats 
were equipped with a chronic heart catheter in the jugular vein allowing repeated 
and stress free blood sampling according to a previously described method 
(Steffens, 1969). Under 2% isoflurane inhalation anesthesia, a silicon heart 
catheter (0.95 mm OD, 0.50 mm ID) was inserted into the right jugular vein and 
kept in place with a ligament. The other end of the catheter was subcutaneously 
directed to the top of the head were it was fixed with dental cement and could 
be used to connect the rats to sampling tubes. After 10 days of recovery from 
surgery, rats were divided over four groups (n=8 in each group): home cage 
control on standard Chow food (Control-Chow) or medium fat food (Control-
MF), and sleep restriction on standard Chow food (SR-Chow) or medium fat food 
(SR-MF). After 8 days of sleep restriction, rats were prepared for blood sampling 
by connecting them to sampling tubes. After 1h, when any handling effect should 
have disappeared, rats received an intravenous injection of 8-OHDPAT stress 
free through the catheter at a concentration of 0.1 mg/kg body weight (Novati et 
al., 2008). To measure plasma levels of ACTH and corticosterone in response 
to serotonin 1A receptor stimulation, blood samples were taken shortly before 
as well as 10, 20, 30 and 60 min after the 8-OHDPAT injection. All samples had 
a volume of 250 μl, except the first one, which had a volume of 500 μl to allow 
analysis of plasma levels of insulin and leptin. The blood samples were collected 
in pre-cooled tubes containing EDTA (20 μL/ml blood). The samples were 
centrifuged at 2600g for 10 min and plasma was stored at −20 °C until analysis. 
Plasma ACTH levels were measured by ImmuChem 125l ACTH Radioimmunoassay 
and plasma corticosterone levels were measured by ImmuChem 125I Corticosterone 
Radioimmoassay (MP Biomedicals, Orangeburg, NY, USA). Plasma insulin levels 
were measured by Linco Research Rat Insulin Radioimmoassay and plasma 
leptin levels were measured by Linco Research Rat leptin Radioimmoassay (Linco 





Body weight and energy intake data was subjected to an analysis of variance 
(ANOVA) with repeated measures. Effects of sleep restriction and diet on the 
8-OHDPAT induced temperature response in experiment 1 and endocrine 
responses in experiment 2 were assessed with repeated measures ANOVA as 
well. Effects of the treatments on plasma insulin and leptin levels were analyzed 
with two way ANOVA. When appropriate, posthoc Tukey test was applied to 
establish differences between specific groups. P<0.05 was considered statistically 
significant. All data in text and figures are expressed as averages ± SEM.
Results
Experiment 1: serotonin 1A induced temperature responses
During the 8-day experiment, sleep restricted rats on standard Chow food 
significantly decreased in body weight compared to control rats on Chow 
(Repeated Measures ANOVA, sleep restriction x time: F(11,154)=33.58, P<0.001) 
(Figure 1A). Sleep restricted rats on Chow also lost significantly more weight 
than sleep restricted rats on MF food (Repeated Measures ANOVA, diet x time: 
F(11,154)=7.19, P<0.001). Despite the gradually developing differences in body 
weight, all groups maintained a stable and similar energy intake (average energy 
intake per day: Control-Chow: 88.6 ± 2.1 kCal; SR-Chow: 85.4 ± 2.7 kCal; SR-MF: 
85.2 ± 1.8 kCal).
 The subcutaneous injection of the serotonin 1A agonist caused an immediate 
hypothermia that reached lowest levels around 20-30 min post-injection (Figure 
1B). Body temperature returned to control values after 80 min. Sleep restricted 
rats on the standard Chow diet displayed a significantly attenuated temperature 
response compared to control rats on Chow (Repeated Measures ANOVA, sleep 
restriction x time: F(12,144)=3.60, P<0.001). Sleep restricted rats on MF showed 
the same attenuated response and did not differ from the sleep restricted rats on 
Chow (Repeated Measures ANOVA, diet x time: F(12,144)=0.70, P>0.5).  
Experiment 2: serotonin 1A induced endocrine responses 
Similar to experiment 1, both sleep restriction and diet affected body weight 
(Figure 2A).  Two Way Repeated Measures ANOVA revealed a significant effect 
of diet (diet x time: F(11,308)= 4.07, P<0.001), sleep restriction (sleep restriction 
x time: F(11,308)= 58.97, P<0.001), and an interaction between the two (sleep 
restriction x diet x time: F(11,308)=3.00, P<0.01). The home cage control groups 
on the two different diets did not differ from each other. Sleep restriction caused 
a decrease in body weight but, as in the first experiment, this effect was strongly 
attenuated in the rats on MF food. Again, energy intake was not different between 
groups (average energy intake per day: Control-Chow: 88.6 ± 2.1 kCal; Control-
MF: 87.6 ± 1.9 kCal; SR-Chow: 89.4 ± 2.0 kCal; SR-MF: 88.9 ± 2.0 kCal). 
 The injection of 8-OHDPAT induced a clear activation of the hypothalamic-
pituitary-adrenal axis in all treatment groups (ACTH: Figure 2B, corticosterone: 
Figure 2C). The ACTH response was not affected by diet but ANOVA revealed a 
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significant overall effect of the 8 days sleep restriction (F(1,26)=4.70, P<0.05). 
On average sleep restricted rats had a slightly attenuated ACTH response as 
compared to the control rats. In contrast, the corticosterone response to 8-OHDPAT 
was not affected by prior sleep restriction but, instead, was significantly affected 
by diet (diet x time: F(4,108)=12.07, P<0.001). The MF diet caused a significantly 
stronger corticosterone response compared to the standard Chow diet. 
 Eight days of sleep restriction decreased both leptin and insulin levels 
compared to control rats (Two Way ANOVA: Leptin: F(1,27)= 21.32, P<0.01; 
Insulin: F(1,27)=14.63, P<0.001), while a MF diet increased both leptin and 
insulin levels compared to rats on a Chow diet (Two Way ANOVA: Leptin: F(1,27)= 
12.19, P<0.001; Insulin: F(1,27)=4.58, P<0.05), but no interaction effects were 
found (Figure 3).
Figure 1: The effects of 8 days of sleep restriction on body weight and serotonin 1A sensitivity in rats 
receiving a standard Chow diet or a MF diet: (A) body weight changes in the course of the experiment; 
(B) body temperature responses to an injection with the serotonin 1A agonist 8-OHDPAT (0.25 mg/kg) 
after 8 days of restricted sleep. The horizontal grey bar at the bottom of graph 1A represents the 8-day 
period of sleep restriction. N=8 in each group. Data are presented as average values ± SEM. See text 




Figure 2: The effects of 8 days of sleep restriction on body weight and serotonin 1A sensitivity in rats 
receiving a standard Chow diet or a MF diet: (A) body weight changes in the course of the experiment; (B) 
ACTH and (C) corticosterone responses to an injection with the serotonin 1A agonist 8-OHDPAT (0.1 mg/
kg) after 8 days of restricted sleep. The horizontal grey bar at the bottom of graph 2A represents the 8-day 
period of sleep restriction. N=8 in each group. Data are presented as average values ± SEM. See text for 
details on statistics.
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Discussion
In the present study we aimed to assess whether SR induced changes on serotonin 
1A sensitivity are a secondary consequence of changes in metabolism and body 
weight. Providing sleep restricted rats with a MF diet strongly attenuated the drop 
in body weight that is normally seen in sleep restricted rats on a standard Chow 
diet. However, this did not prevent the desensitization of the serotonin 1A system. 
Sleep restricted rats on both MF and standard Chow showed a similarly blunted 
body temperature response and pituitary ACTH response upon stimulation of the 
serotonin 1A receptor system by an injection of the agonist 8-OHDPAT. 
 Interestingly, the MF diet caused a significant increase in the adrenal 
corticosterone response, independent of sleep restriction, suggesting that fat food 
per se may increase adrenal sensitivity. This finding appears to be in line with 
other published studies on the consequences of a chronic high fat diet. Indeed, 
rats on a high fat diet have enlarged adrenals, increased basal corticosterone 
levels, and increased adrenal responses to challenges during the first months on 
the diet (Tannenbaum et al., 1997). Even though in our study basal corticosterone 
levels were not affected, the corticosterone response to the 8-OHDPAT challenge 
was. Perhaps the MF food used in this experiment had the same effect on the 
adrenals compared to a high fat diet. Future experiments should therefore take 
adrenal size into account.
 The MF diet in the present study was administered to prevent the decrease in 
body weight that is normally seen during sleep restriction. As expected, rats on the 
MF diet did not lose as much weight as rats on regular Chow did. Nevertheless, 
the MF diet did not prevent the changes in serotonin 1A sensitivity seen after 
sleep restriction. Since the MF diet did not prevent the decrease in body weight 
completely, an effect of body weight loss during sleep restriction on the 5-HT1a 
desensitization cannot be fully excluded. One might argue that even the smaller drop 
in weight in the MF rats could be sufficient to cause a maximal 1A desensitization 
that could not worsen by the additional weight loss in the Chow rats. However, 
this possibility does not seem likely in light of other published studies. Particularly, 
a study on the consequences of social stress showed that a high fat diet was 
able to partially prevent the stress-induced drop in body weight and at the same 
time completely prevented the stress-induced desensitization of the serotonin 1A 
receptor (Buwalda et al., 2001). Thus, whereas fat food ameliorates the effects of 
stress on the serotonergic system, it does not seem to protect against the effects 
of sleep restriction. Apparently, the mechanisms through which stress and sleep 




Although the sleep restricted groups on control and MF diet differed in body weight, 
they had a similar energy intake as calculated from their food intake and the caloric 
content of their respective diets. Possible explanations for this discrepancy are that 
rats on a fat diet increase the actual absorption of energy in the intestinal system 
or a fat diet somehow lowers energy expenditure (Buwalda et al., 2001;Koolman 
et al., 2010;Morens et al., 2006). Literature shows that sleep restriction increases 
energy expenditure (Everson, 1995;Rechtschaffen and Bergmann, 1995) and a 
MF diet might influence this in such a way that it attenuates weight loss compared 
to rats on a standard Chow diet.
 Both sleep restriction and diet had specific and independent effects on basal 
levels of insulin and leptin. Sleep restriction decreased the levels of these 
hormones whereas a MF diet increased them. These changes may in part reflect 
the changes in body weight and fat content in the different groups (Picarel-Blanchot 
et al., 1995;Redman and Ravussin, 2009). It remains unclear though why sleep 
restricted rats on a MF diet did not have significantly higher insulin and leptin 
levels compared to the sleep restricted rats on a standard Chow diet. Yet, the 
changes in the levels of these metabolic hormones may be relevant in the context 
of the changes in serotonin 1A sensitivity that we found. Particularly changes in the 
Figure 3: The effects of 8 days of sleep restriction on plasma levels of leptin (A) and insulin (B) in rats 
receiving a standard Chow diet or a MF diet. N=8 in each group. Data are presented as average values ± 
SEM. See text for details on statistics.
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regulation of insulin may be associated with altered serotonin receptor sensitivity 
(Li et al., 2009). Rats receiving an intraperitoneal injection with streptozotocin, 
which is extremely toxic for the −-cells in the pancreas, have a decreased insulin 
production similar to what is seen in diabetic patients (Rerup, 1970). After the 
injection, rats become hyperglycemic and hyperphagic but have decreased body 
weights, which is all normalized after insulin treatment (Friedman, 1977;Friedman, 
1978;Friedman and Ramirez, 1994). Li and colleagues (Li et al., 2009) showed 
that the body temperature response to an 8-OHDPAT challenge was decreased 
7 days after a streptozotocin injection, indicating reduced serotonin 1A sensitivity 
very much like in our sleep restricted rats. Again, the effect was reversible after 
10 days of insulin treatment. It might thus be that an altered insulin regulation 
contributes to a desensitization of the serotonin 1A system in sleep restricted rats.
 Clearly, the exact mechanism through which chronically restricted sleep gradually 
desensitizes the serotonin 1A system may be complex and multifactorial. It may in 
part be the result of altered regulation of physiological and endocrine factors such 
as insulin and it may in part be the consequence of a cumulative effect of sleep 
loss directly acting on the brain. 
 In conclusion, a MF food diet partially prevents the drop in body weight but not 
the desensitization of the serotonin 1A receptor system in sleep restricted rats. 
Chronically sleep restricted rats on both a standard Chow or MF diet showed 
a similarly blunted temperature response and blunted pituitary ACTH response 
to stimulation of the 1A receptors with the agonist 8-OHDPAT. The physiological 
and molecular mechanism through which sleep restriction gradually alters the 
serotonin 1A sensitivity remains to be established.
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Sleep disturbances, induced by either life style, shift work or sleeping disorders, 
have become more prevalent in our Western 24/7 society. Sleep disturbances 
are associated with impaired health including metabolic diseases such as obesity 
and type 2 Diabetes. The question remains whether there is a direct effect of 
disturbed sleep on glucose homeostasis. Experimental studies under controlled 
laboratory conditions in both humans and experimental animals revealed that there 
are differences between the effects of acute or chronic sleep disturbance. 
Acute sleep restriction clearly leads to glucose intolerance often combined 
with insulin resistance. Glucose intolerance does also occur after chronic sleep 
disturbance but the changes in insulin may vary, dependent on the body weight 
changes in the various studies. The underlying mechanism that may cause the 
changes in glucose homeostasis after sleep disturbance remain unclear but 
both the biological clock located in the nucleus suprachiasmaticus as well as 
orexinergic mechanisms in brain and periphery seem to be involved.
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Introduction
Over the past 50 years, average sleep duration in Western societies has decreased 
by 2 hours per night (Van Cauter et al., 2005). Initially, this decrease is sleep 
has been mainly observed in adulthood, but recent epidemiological studies have 
shown a similar decrease in children and adolescents (for reviews see: Horne, 
2008;Van and Knutson, 2008). A decrease in sleep includes not only the 
duration but also the quality of sleep. Quality of sleep is generally defined in 
terms of changes in sleep architecture, the content of dreaming and the amount 
of awakenings (for a review see: Vandekerckhove and Cluydts, 2010). 
 A decrease in sleep length or quality of sleep has important consequences 
on an individual’s well-being. Sleeping problems are linked to many health and 
lifestyle problems such as increased errors, loss of productivity, sleepiness 
during the day, impaired social activities and an elevated risk for accidents 
(for a review see: Banks and Dinges, 2007;Horne and Reyner, 1999). 
Disturbed sleep has also been identified as risk factors for various diseases 
including psychiatric disorders such as depression (Breslau et al., 1996;Ford 
and Kamerow, 1989;Neckelmann et al., 2007) and immune system dysfunctions 
(Imeri and Opp, 2009;Irwin, 2002;Opp and Toth, 2003). These health problems 
are increasing since sleep loss and decreased sleep quality are becoming 
more and more prevalent in our current 24/7 Western society, 
Metabolic consequences of sleep disturbances
Sleep disturbances are also linked to metabolic dysfunctioning. Studies in 
shift workers provided the first (indirect) evidence for a relation between sleep 
disturbances and impaired metabolism. Shift work has become more prevalent 
in the last decades and shows clear negative effects on sleep timing, length and 
quality (Dumont et al., 1997). Shift workers are active during the night and they 
sleep and eat at abnormal hours. They fall asleep in the morning, but are awakened 
ahead of time due to their circadian rhythm, causing them to exhibit sleepiness 
and reduced performance (Akerstedt, 1990). The shift work - induced changes, 
in particular sleep loss and disturbed circadian rhythmicity in eating and energy 
expenditure, are associated with an increased susceptibility to develop obesity, 
type 2 diabetes and cardiovascular disorders (Akerstedt et al., 2004;Knutsson, 
2003).
 There is also a direct correlation between disturbed sleep and obesity, the 
main risk factor for developing cardiovascular diseases and type 2 diabetes. 
Evidence for this comes from several epidemiological studies, among others 
described by Caput and Van Cauter (Chaput et al., 2007;Van Cauter et al., 2007). 
In addition, the group of Gottlieb and co-workers (Gottlieb et al., 2005) provided 
evidence for a direct correlation between disturbed sleep and the increased 
prevalence of type 2 diabetes, independent of changes in body weight.
 Another striking example for the relation between disturbed sleep and increased 
risk on metabolic disorders derives from studies on patients with obstructive sleep 




sleep, which usually leads to arousals to resume breathing. The patients suffer 
from sleep fragmentation and hypoxemia, causing disturbed sleep architecture 
and increased amount of awakenings (Bandla and Gozal, 2000;Svanborg and 
Guilleminault, 1996). OSA primarily changes the quality of sleep while total sleep 
time is not dramatically altered. Vgontzas and colleagues (Vgontzas et al., 2003) 
were the first to show that there is a relation between OSA and obesity, type 2 
diabetes and cardiovascular disease. In fact, there is bidirectional relationship: 
OSA leads to obesity but obesity does also directly affect OSA: weight gain or 
weight loss leads to a significant worsening or improvement, respectively, of sleep 
apnea in adults (Peppard et al., 2000;Pillar and Shehadeh, 2008). OSA is also 
directly associated with insulin resistance and glucose intolerance, independent 
of changes in weight (Punjabi et al., 2002). 
Human studies on sleep and glucose homeostasis
The main point of the above is that disturbed sleep is clearly associated with an 
increased risk on type 2 diabetes, even when corrected for BMI or fat content of 
the body (Chaput et al., 2009;Gottlieb et al., 2005). This leads to the question: 
is there a direct effect of (disturbed) sleep on glucose and insulin regulation? 
To answer this question, experimental studies under controlled laboratory 
conditions are required. These studies, both in humans and experimental animals, 
are recently performed in different labs.
 In experimental studies in humans, most experimenters standardize the 
experimental protocol by providing standard meals at fixed time points of the day 
and by requiring the subjects to stay in bed during the sleep restriction hours to 
minimize activity. Unfortunately, there is still a large variation in the experimental 
set up of the sleep restriction protocols, in particular in the length of the sleep 
restriction period which may vary from acute one night total sleep deprivation up 
to periods of 6 nights of partial sleep deprivation. These differences in length of 
the sleep restriction protocols markedly influenced the outcomes of the different 
studies.
 The first experimental study in humans was published in 1993, when VanHelder 
and colleagues showed that sixty hours of sleep deprivation led to an increased 
plasma insulin response without changes in blood glucose during an oral glucose 
tolerance test (OGTT) (VanHelder et al., 1993). Similar data after one night of 
sleep restriction have been found in a recent study by Donga et al (Donga et al., 
2010) in which insulin sensitivity was measured with the gold standard method 
for measuring insulin sensitivity: a hyperinsulineamic euglycemic clamp. In this 
study, one night of sleep restriction (four hours in bed) was sufficient to develop 
moderate insulin resistance, reflected by a decreased glucose infusion rate, 
a reduced glucose disposal rate and increased endogenous glucose production. 
In this study, the baseline glucose and insulin levels were not different from 
controls. 
 In 1999, Spiegel and colleagues showed that six days of partial sleep restriction 
(subjects were allowed to sleep only four hours per night) led to glucose intolerance 
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reflected by a significant elevation of blood glucose levels during an intravenous 
glucose tolerance test (IVGTT) (Spiegel et al., 1999). Surprisingly, there was no 
reduction in insulin sensitivity. Instead, it was observed that plasma insulin levels 
were decreased after six days of sleep disturbance which is, of course, in sharp 
contrast with the data from VanHelder and Donga (Donga et al., 2010;VanHelder 
et al., 1993). However, in a follow up study from the same lab (Tasali et al., 2008), 
they found that sleep disturbance could indeed lead to reduced insulin sensitivity 
and glucose intolerance. In this particular study, the subjects were submitted to 
an IVGTT and sleep disturbance was defined as three nights of experimentally 
suppressed slow wave sleep without changes in total sleep time. This also allows 
the conclusion that it is not only the quantity of sleep but also the quality of sleep 
that is important. 
 Although many of these human data are seemingly in conflict with each other, 
one may still conclude that sleep disturbance has a marked impact on glucose 
and insulin homeostasis. When searching for a common denominator, it seems 
that acute sleep disturbances may to lead to insulin resistance and in some cases 
glucose intolerance, whereas longer periods of disturbed sleep has no direct effect 
on insulin sensitivity but the glucose intolerance remains. One may speculate 
that the insulin resistance after acute total sleep deprivation is secondary to the 
(stress-induced) activation of the HPA-axis elevation reflected by the elevated 
cortisol levels in the evening after a night without sleep (Leproult et al., 1997). 
This acute stress response may be less pronounced in the longer sleep restriction 
studies where the subjects are still allowed to sleep for a few hours per night. 
However, Spiegel and colleagues (Spiegel et al., 1999) still found increased 
cortisol levels after the six days of sleep restriction although this increase was less 
pronounced when compared to the acute response after one night without sleep.
Animal studies on sleep and glucose homeostasis - rat studies
As mentioned before, human studies may vary in length between acute sleep 
deprivation to a maximum of up to six days of sleep restriction. Animal studies are 
required for studies on chronic sleep disturbance for investigation of the underlying 
mechanisms. Most animal studies in (chronic) sleep research are performed in 
rodents and experimental methods to prevent the animals from sleeping may vary 
from gentle handling to small balance platforms and forced activity. The different 
methods are discussed below.
 The gentle handling method (Van Der Borght et al., 2006) is comparable to the 
sleep restriction protocol in human experiments. The animals, mostly rats, are kept 
awake by a protocol that includes tapping on the cage, shaking the cage gently 
or, if required, disturbing the nest. This method is mainly used in acute or short 
time sleep deprivation experiments, since the experimenter is required to be 
present continuously during the experiments. In our laboratory, 12h of sleep 
deprivation by means of gentle handling had no effect at all on baseline levels of 
blood glucose, plasma insulin and plasma corticosterone. 




experiments. Two methods are described in literature the flower pot and the single 
platform method. Both methods are used to deprive rats of REM sleep only and 
the principle is as follows: to induce REM sleep deprivation, rats are placed inside 
a water chamber onto a flower pot or a platform of about 7.0cm in diameter. 
The platform is in the water up to 1.0cm of the platform upper surface. The method 
is based on the loss of muscle tonus that occurs during REM sleep. This means 
that if the rat enters the REM sleep stage, it loses muscle tonus and will touch 
the water after which the rat will wake up (Cohen and Dement, 1965). When this 
method is used to deprive rats of REM sleep for 4 days, it leads to a decrease in 
plasma insulin levels which is secondary to a significant reduction in body weight 
(Hipolide et al., 2006). 
 Another commonly used method in animal sleep restriction research is the 
disk over water method, extensively described by Rechtschaffen and colleagues 
(Rechtschaffen and Bergmann, 1995;Rechtschaffen and Bergmann, 2002) 
In short, the experimental animal is housed on a horizontal disk above water. 
The electromyograph (EMG) and the electroencephalograph (EEG) are 
continuously recorded to detect sleep states. When the experimental rat starts 
to sleep or enters a certain sleep stage, the disk starts to rotate at a low speed. 
This causes the awakening of the rat and forces it to walk to avoid being 
carried into the water. There is only one study in which this method was used 
to investigate glucose homeostasis after a longer period of sleep deprivation. 
In this study by Everson and colleagues, they measured glucose disappearance 
after a dextrose injection. The data revealed that there was a tendency towards 
somewhat lowered glucose levels after sleep deprivation (Everson et al., 1989).
 In our laboratory, we use a forced activity paradigm known as the slowly rotating 
drum to sleep deprive the rats. This method was originally described in 1984 by 
Borbely and colleagues (Borbely et al., 1984). In our studies, the experimental 
animals are placed for twenty hours per day in a rotating drum (Figure 1) that 
is rotating at a constant speed of 0.4cm/min (Barf et al., 2010;Novati et al., 
2008;Roman et al., 2005). In this way the animals are allowed to sleep only for 
(the remaining) four hours per days.  We generally include a control group that 
walks twice the speed (0.8cm/min) but half the time to control for the forced activity 
in this protocol. Our latest studies focused on the difference between acute and 
chronic sleep deprivation on glucose homeostasis and insulin levels. To this end, 
we performed an intravenous glucose tolerance test (IVGTT) after 1 day and 8 
days of sleep restriction. The data revealed that a reduction in sleep markedly 
interfered with glucose metabolism (Barf et al., 2010). Acute sleep restriction 
was accompanied with elevated blood glucose profiles without any changes in 
plasma insulin levels during an IVGTT. The effects of chronic sleep reduction are 
presented in Figure 2. The observed glucose intolerance is still present after 8 days 
of sleep restriction which is similar to the data obtained in most human studies. 
Baseline insulin levels and glucose-stimulated insulin responses were lower after 
chronic sleep reduction. This effect on insulin was, similar to the data in humans 
obtained by Spiegel et al in 1999, secondary to the weight loss after chronic sleep 
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Figure 1: Slowly rotating drum
Figure 2: Blood glucose and plasma insulin levels in response to a 30-min intravenous glucose infusion after 
one (graphs A and C) and 8 (graphs B and D) days of restricted sleep (RS) or controls. The horizontal grey 
bars at the bottom of each graph represent the 30 min of 15% glucose infusion. Data are average values 




reduction. Based on the data above, we may conclude that the effects of sleep 
restriction on glucose homeostasis in experimental animals are remarkably similar in 
rats and humans. Acute sleep restriction leads to glucose intolerance in combination 
with unchanged insulin levels (all rat models and some human studies) or insulin 
resistance (other human studies). The glucose intolerance remains prevalent after 
chronic sleep restriction, both in humans and rats. Chronic sleep restriction may 
also lead to a reduction in plasma insulin levels but this effect seems secondary 
to a reduction in body weight. The reduction in body weight is typical for 
experimental studies under controlled conditions and in sharp contrast with 
epidemiological data that suggest that long term sleep disturbances are 
associated with weight gain and the development of obesity and, consequently, 
the development of insulin resistance and type 2 Diabetes. The insulin resistance 
that occurs after one night of total sleep deprivation in the (human) experimental 
studies seems primarily caused by a (stress-induced) activation of the HPA-axis, 
reflected by the elevated cortisol levels under these circumstances.
Possible mechanisms underlying glucose intolerance
The data above raises the question: what is the cause of the glucose intolerance 
that occurs after both acute and chronic sleep deprivation? Is it mainly a 
behavioral effect, related to changes in food intake, physical activity and 
energy expenditure? Or is it caused by (circadian) disturbances in hormonal 
outflow and/or the activation of the autonomic nervous system? Or is hyperglycemia 
mainly secondary to changes at the level of the central nervous system, 
in particular at orexinergic neurons in the lateral hypothalamus? Some of these 
options will be discussed below. 
 The biological clock, located in the suprachiasmatic nucleus (SCN), has a 
marked effect on glucose homeostasis. There are clear differences in the glucose 
and insulin responses to an IVGTT in both rats and humans at different times 
of the circadian clock (for review see: Kalsbeek et al., 2010). This circadian 
rhythmicity in glucose regulation disappears when the SCN is lesioned (La Fleur 
et al., 2001). One may state that the biological clock does not only influence the 
sleep-wake cycle, but also prepares the glucose regulatory mechanisms for the 
changes in energy uptake and expenditure at different time points of the day/
night cycle. These circadian systems are tightly integrated and problems may 
occur when our daily activities are not in synchrony with our sleep-wake cycle, 
for example during shift work and  periods of disturbed sleep (Knutsson, 2003). 
For example, when rats are forced to be active in their non-active phase, they 
will eat at the wrong time of the day and consequently increase in body weight 
compared to controls (Salgado-Delgado et al., 2008). This weight gain can be 
prevented when the animals are only allowed to eat in the (normal) active phase 
and not in the shift work period (Salgado-Delgado et al., 2010).
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Hormonal influences also seem to be involved in the effects of disturbed and 
restricted sleep in glucose metabolism. In humans, sleep deprivation has been 
shown to decrease plasma leptin and to increase plasma ghrelin levels, leading to 
increased hunger and appetite (Spiegel et al., 2004).  At a central level, orexinergic 
system in the brain seems to play a role as well. Orexin is involved in both food 
intake, energy expenditure and the sleep-wake cycle and could therefore be an 
interesting link between sleep disturbances and the increased prevalence of obesity 
and type 2 diabetes (Sakurai, 2002;Sakurai, 2007). For example, narcolepsia is 
a disease that is characterized by reduced orexin levels in the central nervous 
system causing less consolidated wake periods, leading to a sudden appearance 
of sleep periods. Narcolepsia is associated with an increased frequency of type 
2 diabetes (Honda et al., 1986). Peripheral orexin seems to be involved as well 
since orexin receptors have been found on the pancreas and other peripheral 
organs (Adeghate et al., 2010). It is also known that orexin plays a direct role 
in the regulation of glucose homeostasis. Tsuneki and colleagues showed that 




orexin neurons directly respond to the nutritional status of an individual and is 
modulated by metabolic signals such as glucose, leptin and ghrelin (Tsuneki et 
al., 2010;Yi et al., 2009). Studies in orexin knockout mice point to a contribution of 
orexin in the age-related development of impaired glucose tolerance, independent 
of obesity (Tsuneki et al., 2008). Finally, it is known that orexin is directly involved 
in the regulation of energy expenditure. Increased orexin levels correspond with 
increased physical activity and increased non-exercise thermogenesis (NEAT) 
and, consequently, glucose utilization. Taken together, these data show that orexin 
may serve as a crucial factor in the relation between sleep loss, circadian rhythms, 
physical activity and the effects on glucose metabolism (Figure 3).
 In summary, sleep disturbances are directly associated changes in glucose 
homeostasis. Experimental studies under controlled laboratory conditions in 
both humans and experimental animals revealed that there are differences 
between the effects of acute or chronic sleep disturbance. Acute sleep 
restriction clearly leads to glucose intolerance often combined with insulin 
resistance. Glucose intolerance does also occur after chronic sleep 
disturbance but the changes in insulin may vary, dependent on the body weight 
changes in the various studies. The underlying mechanisms that may 
cause the changes in glucose homeostasis after sleep disturbance remain 
unclear but both the biological clock located in the nucleus suprachiasmaticus 
as well as orexinergic mechanisms in brain and periphery seem to be involved.
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This thesis aimed to study restricted or disrupted sleep in rats in a controlled 
laboratory setting to allow a detailed assessment of the metabolic consequences 
of sleep loss and its underlying mechanisms. Based on the human epidemiology, 
we expected that chronic sleep restriction would lead to increased food intake, 
weight gain and insulin resistance. However, we found that chronic sleep restriction 
attenuates weight gain with no change in food intake or insulin resistance. In 
addition, we observed that sleep restriction leads to hyperglycemia, both acutely 
and after 8 days of sleep restriction (chapter 3). Furthermore, chronic sleep 
restriction led to increased energy expenditure, which may explain the attenuated 
weight gain (chapter 2). Changing the sleep restriction model by including 2 days 
of undisturbed sleep per week did lead to increased food intake and weight gain in 
comparison to continuously sleep restricted rats although the weight gain was still 
lower than in home cage controls (chapter 6). The hyperglycemia and attenuated 
weight gain appears to be a direct consequence of disturbed or insufficient 
sleep and not a non-specific byproduct of our sleep deprivation model, since 
hyperglycemia was not observed in control studies in which rats were exposed 
to forced running (chapter 4) or a circadian disruption protocol in which rats were 
forced to be active for 8 hours during the light (inactive) phase (chapter 5). 
Sleep quantity vs. sleep quality
An important question is whether the metabolic consequences of sleep restriction 
are due to a change in the sleep quantity or sleep quality. In chapter 3 we 
demonstrated that chronically disturbed sleep led to an attenuation of weight 
gain, despite the fact that rats were allowed to sleep for 14h per day. In addition, 
intravenous glucose tolerance test (IVGTT) data demonstrated a hyperglycemia 
together with a decrease in insulin response, similar to sleep restricted rats. To 
compare total sleep time between both groups we measured sleep EEG also in 
our sleep disturbed rats (Figure 1). During a baseline day, rats slept approximately 
11h. In chapter 2 we demonstrated that our sleep restriction protocol led to a 
60% decrease of total sleep time. Although sleep disturbed rats had 14h of sleep 
allowance per day, the protocol still led to a 20-30% decrease in total sleep time. 
Thus, sleep disturbed rats slept more than sleep restricted rats, but considerably 
less compared to their own baseline day. We cannot exclude that this reduction in 
total sleep time was responsible for the changes in glucose tolerance and weight 
gain. However, since the consequences were not more pronounced in the sleep 
restricted rats, we can conclude that a more severe sleep restriction protocol does 
not necessarily lead to more extreme consequences. 
 Interestingly, when we only disturbed the circadian aspect of sleep, by means of 
a shift work protocol that forced rats to be active during their normal sleep phase, 
a small attenuation of weight gain was found but no effect on glucose tolerance 
(chapter 6). We did not perform EEG measurements in these shift work rats, but it 
may be that this protocol only affected the timing of sleep and not sleep quantity 




often associated with disturbed sleep (Akerstedt, 2003), such disturbances may 
not occur under optimal laboratory conditions. Indeed, it has been shown in at 
least one human laboratory experiment that, under optimal conditions, one week 
of shift work did not affect total sleep time or sleep architecture (Lamond et al., 
2003). Similarly, our shift work rats may have had shifted, but normal amounts of 
consolidated sleep, thereby preventing the metabolic consequences seen in our 
sleep restricted and sleep disturbed rats. 
 To conclude, our data suggest that shifting sleep allowance to the subjective day 
per se does not affect glucose homeostasis, whereas disturbed and/or reduced 
sleep induces glucose intolerance. Therefore, our rat data regarding sleep quantity 
vs. sleep quality  are comparable to the human literature, since both restricted 
sleep (Spiegel et al., 1999) as well as decreased sleep quality (Tasali et al., 2008), 
by means of suppressed deep sleep without changes in total sleep time, lead to 
reduced glucose tolerance.
Sleep restriction and the orexinergic system
The neuropeptides orexin A and orexin B (also known as hypocretin 1 and 
hypocretin 2) may play an important role in the metabolic consequences of chronic 
sleep restriction. Orexin neurons were independently discovered by two different 
groups (de Lecea et al., 1998;Sakurai et al., 1998;Peyron et al., 1998). Both found 
that orexin neurons are localized to the lateral hypothalamus (LH). Since the 
Figure 1: Time spent asleep or wakefulness during baseline, day 1 and day 8 of sleep disturbance and a 
recovery day (n=5). Time spent asleep is divided into NREM and REM sleep. Data are average values ± 
SEM. Statistics are done on total sleep time and total wake time. Asterisks indicate a significant difference in 
comparison to baseline (* P<0.05). 
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LH area is known as the feeding center, it was thought that orexin was involved 
in food intake. Indeed, ICV injections of orexins during the light period induced 
feeding behavior in both rats and mice (Haynes et al., 2000;Sakurai et al., 1998). 
In addition to the effects of orexin on feeding behavior, orexin knockout mice also 
show a remarkably similar phenotype to human narcolepsy patients. Narcolepsy 
is a disease that is characterized by severe sleep disturbance, less consolidated 
wake periods and sudden appearances of sleep bouts. Studies in patients indeed 
confirmed that narcolepsy is associated with a pronounced orexin deficiency 
(Peyron et al., 2000;Thannickal et al., 2000). Importantly, narcolepsy patients 
often suffer from metabolic disorders such as obesity and type 2 diabetes (Honda 
et al., 1986). Likewise, studies in orexin knockout mice point to a contribution of 
orexin in the age related development of impaired glucose tolerance independent 
of obesity (Tsuneki et al., 2008). In addition, it has been found that orexin neurons 
directly respond to metabolic signals such as glucose, insulin, leptin and ghrelin 
that reflect the nutritional status of the body (Tsuneki et al., 2010;Yi et al., 2009). 
Finally, it is known that orexin is directly involved in the regulation of energy 
expenditure. An increase in orexin levels increases physical activity, non-exercise 
thermogenesis and, consequently, glucose utilization (for review: Ganjavi and 
Shapiro, 2007). Taken together, the literature suggests that orexin may be a 
crucial factor in the relationship between sleep loss, physical activity, food intake 
and glucose metabolism.
 Other research has focused on the effects of sleep deprivation on orexins and its 
receptors. However, there are still many inconsistencies. REM sleep deprivation 
using the flower pot method leads to increased orexin A levels in the CSF 
(Pedrazzoli et al., 2004)  and  an increased number of immune-reactive orexin A 
neurons in the LH (Galvao et al., 2009), but has no effect on the mRNA levels of 
prepro-orexin, the precursor of both orexin A and B (D’Almeida et al., 2005). After 
24h of recovery sleep, orexin A levels in the CSF were reduced (Pedrazzoli et 
al., 2004), whereas another study showed a significant increase in prepro-orexin 
mRNA expression in the LH as well as a pronounced increase in orexin receptor 
1 mRNA expression in multiple brain areas after sleep rebound (D’Almeida et al., 
2005). Total sleep deprivation for 24 hours increases the concentration of orexin 
A in CSF of dogs (Wu et al., 2002), and 6 hours of sleep deprivation increases 
orexin A in the LH as measured by micro-dialysis in rats (Yoshida et al., 2001). 
In contrast, the same amount of sleep deprivation did not affect orexin A mRNA 
expression in rats (Terao et al., 2000). Thus, it seems that variations in sleep 
deprivation differentially affect orexin at the mRNA and protein level. Nonetheless, 
sleep deprivation leads to increased orexin A expression independent of method 
or length of the protocol.
 If, along the same lines, orexin A expression is increased in our sleep restriction 
protocol as well, one might expect that sleep restriction leads to changes at the 
receptor level in certain brain areas. Abundant amounts of orexin may lead to 
desensitization and, in turn, to down-regulation of the receptors (Freedman and 




blot analyses for measurements of orexin receptor 1 in both the prefrontal cortex 
and the thalamus (including hypothalamus) after 8 days of sleep restriction. 
The results in Figure 2 show no differences between sleep restricted rats and 
home cage controls, thus we can conclude that the orexin receptor 1 is not down 
regulated. These data do not support the idea that the metabolic consequences 
of chronic sleep restriction are mediated by changes in the orexinergic system. 
However, to completely understand the effect of sleep restriction on orexins and 
its receptors, future studies should focus on all aspects of the neuropeptides as 
opposed to focusing only on mRNA levels, proteins, or its receptors. 
Sleep restriction and obesity
In our studies, chronic sleep restriction led to an attenuation of weight gain in rats, 
whereas the literature reports a clear association between short sleep and the 
development of obesity in humans (Chaput et al., 2006;Chaput et al., 2008;Knutson 
and Van Cauter, 2008;Snell et al., 2007). The question remains what the reason 
for this discrepancy between human epidemiology and animal experiments is. 
One explanation is that exposure to chronic sleep restriction differently affects 
energy expenditure in rats and humans. In rats, we demonstrated that the 
attenuation of weight gain in sleep restricted rats is a consequence of increased 
energy expenditure (chapter 2). In humans, however, energy expenditure is not 
affected during sleep restriction (Buxton et al., 2010;Penev, 2007). In fact, it might 
be that chronic sleep restriction in humans, by causing fatigue, is associated 
with reduced day-time activity and thereby a decrease in overall daily energy 
expenditure. In contrast, sleep restricted rats in our forced activity model are 
not able to reduce their activity and thereby maintain an increased energy 
expenditure. This difference in energy expenditure may explain the assumed 
difference in weight changes between human and rat studies. 
 Alternatively, differences in energy intake may explain the discrepancy between 
Figure 2: Orexin receptor 1 expression measured by western blotting in both the prefrontal cortex and 
the thalamus-hypothalamus divided by HPRT data, which is intended for use as a positive control (n=8). 
Data are average values ± SEM. 
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weight changes in sleep restricted laboratory rats and humans as well. In chapters 
2 and 3 we demonstrated that rats did not increase their food intake despite the 
attenuation of weight gain during sleep restriction. Research has shown that total 
sleep deprivation as well as REM sleep deprivation leads to hyperphagia, yet 
rats lose weight (Everson and Crowley, 2004;Hipolide et al., 2006;Koban and 
Stewart, 2006;Koban et al., 2008). In humans, several days of sleep restriction 
did not affect normal food intake but did significantly increase snacking behavior 
in the evening (Nedeltcheva et al., 2009). Although body weights were unchanged 
during the experimental period, authors concluded that the increase in snacking 
behavior, and thus an increase in caloric intake, could be obesity-promoting. 
In our experiments, rats do not have the availability of high caloric snacks or 
choice between different types of food, which may be another explanation for the 
assumed difference in weight changes between human and rat studies.   
  Interestingly, alternating sleep restriction with periods of rest is more common in 
real life. Sleep loss in humans is generally an alternation between sleep restriction 
during the week and recuperation from sleep loss on the weekend (Valdez et 
al., 1996). In contrast, experimental studies in rats often consist of a continuous 
period of sleep restriction without periods of recovery. Therefore, we assessed 
the metabolic consequences of a chronic sleep restriction protocol that modeled 
working weeks with restricted sleep time alternated by weekends with unrestricted 
sleep allowance (chapter 6). We showed that the alternation between periods of 
sleep restriction and sleep allowance led to complex changes in food intake and 
body weight thus preventing weight loss that is normally seen during continuous 
sleep restriction. Yet, even though this protocol of sleep restriction alternated with 
weekends of sleep allowance prevented the attenuation of weight gain, rats did 
not become overweight or obese.
 Perhaps, the duration of sleep restriction is important as well. Experimental 
studies in rats are rarely longer than a few days or weeks. Even in our own lab, 
rats were never sleep restricted for more than a month. It may be that insufficient 
sleep only contributes to obesity when sleep restriction truly becomes a chronic 
condition.
 To summarize, epidemiological studies in humans demonstrate clear 
associations between short sleep and obesity, which has led to the hypothesis 
that insufficient sleep may be a causal factor in the development of obesity. 
Unfortunately, the finding that, in rats, sleep restriction attenuates weight gain 
does not support this hypothesis. There may be several complicating factors that 
could result in different effects of sleep restriction in laboratory rats and humans in 
real life, particularly differences in the way sleep restriction affects overall energy 
expenditure and energy intake. Furthermore, it may be that sleep restriction is a 
risk factor for developing obesity only for certain personality types or people with 
a certain lifestyle. Personality differences may therefore be an important factor 
in the metabolic consequences of sleep restriction as well, which we will further 




Sleep restriction and personality differences
The negative consequences of sleep restriction can differ between individuals (Van 
Dongen et al., 2005). Personality differences may play a major role in sensitivity to 
the development of metabolic disorders. To investigate this, we performed a pilot 
study in which we subjected two selection lines of rats with different coping styles 
to our chronic sleep restriction protocol. For this purpose we studied the Roman 
high avoidance (RHA) and Roman low avoidance (RLA) rats. These selection lines 
were founded by Bignami in 1965 (Bignami, 1965). The rats originate from the 
Wistar strain and were selectively bred on the basis of their performance in a two-
way active avoidance test. RHA rats were bred to rapidly learn shock avoidance, 
whereas RLA rats were bred for non-acquisition of avoidance. Subsequent studies 
showed that these rats not only differ in their shock-avoidance performance but, 
in fact, differ in a wide range of behaviors, such as emotional reactivity and coping 
style. RLA rats are highly emotional individuals with a passive coping style, 
whereas RHA rats are (pro)active rats with low emotional reactivity (Steimer and 
Driscoll, 2005).
 Research demonstrated that sleep architecture is different between both lines 
as well (Steimer et al., 1999). Total sleep time was not different, but RHA rats did 
have an overall increase in REM sleep time, with a concomitant decrease in NREM 
sleep time. However, it is not known whether they respond differently to sleep 
restriction. In our pilot experiment rats of both lines underwent 8 days of sleep 
restriction (n=4 per group). Food intake and body weight was measured daily. 
We hypothesized that, since RLA rats are more emotional and therefore sensitive 
to changes in the environment, they will lose more weight in comparison to RHA 
rats. Interestingly, both RLA and RHA rats had an attenuated weight gain, but 
there were no differences between the lines. Furthermore, we did not detect any 
differences when compared to Wistar rats in our previous experiments (chapters 
2 and 3).
 In chapter 4, we demonstrated that both forced and voluntary running decreases 
the insulin response to an IVGTT in RLA and RHA rats, but this effect is most 
prominent in the RLA rats, since these rats are already insulin insensitive under 
sedentary conditions. The same decrease in insulin response to an IVGTT is seen 
in our Wistar rats during sleep restriction (chapter 3). The question that remains 
is whether RLA and RHA rats differ in their glucose response to an IVGTT after 
sleep restriction, since we found a clear hyperglycemia in Wistar rats after 8 days 
of sleep restriction. It might be that, although both lines of rats have attenuated 
weight gain, they do have a difference in glucose clearance during an IVGTT. This 
would support the notion that personality differences are an important aspect in 
the metabolic consequences of sleep restriction and perhaps the sensitivity to 
metabolic disorders. 
Concluding remarks
Our data demonstrated that chronic, as well as acute, sleep restriction in rats has 
profound effects on glucose homeostasis and energy balance. In addition, we 
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found that alternating sleep restriction with periods of unrestricted sleep prevented 
the attenuated weight gain as seen during continuous sleep restriction. For that 
reason, this week-weekend protocol is interesting, both in the context of glucose 
homeostasis and weight gain. The attenuation of weight gain during continuous 
sleep restriction has always been an important, but unwanted, confounding factor 
when looking at the development of insulin resistance and glucose intolerance, 
since decreased body weight has effects on insulin sensitivity in itself. Therefore, 
this week-weekend protocol is a significant addition to existing research. Future 
experiments should emphasize the effects of chronic sleep restriction, alternated 
with periods of sleep allowance, on glucose homeostasis and insulin sensitivity. 
 Based on our data, future research should also focus on the underlying 
mechanisms of the sleep restriction induced glucose intolerance, especially at the 
central level. The neuropeptides orexin A and orexin B are assumed to be involved 
in the effects of sleep restriction on glucose homeostasis and energy balance, but 
it is not clear to what extent. Once the involvement of these peptides is elucidated 
it might be that the negative consequences of sleep restriction can be controlled 
by therapies targeting the orexinergic system.
 Nevertheless, it is a well-known notion that preventing is better than curing. 
In addition to personality differences in sleep architecture (Steimer et al., 1999) 
it is known that there are individual differences in the amount of total sleep 
one requires. Sleeping 8 hours per night may be right for one, but not enough 
for another. In any case, data obtained from the current studies suggest that 
chronic sleep restriction in the rat is a useful model for determining mechanisms 
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De metabole gevolgen van slaapverstoringen in ratten
Metabole ziekten als overgewicht en type 2 diabetes komen steeds meer voor in 
de Westerse wereld. Deze toename kan niet alleen verklaard worden door een 
verhoogde voedselinname en/of verminderde fysieke activiteit. De hoeveelheid 
slaap is de laatste jaren ook sterk afgenomen. Recent onderzoek, ondermeer 
door de groep van Van Cauter in Chicago, heeft aangetoond dat ook een tekort 
aan slaap of een verstoring van de slaap kan leiden tot de ontwikkeling van deze 
metabole ziekten. Het is echter nog niet duidelijk of er daadwerkelijk sprake is 
van een oorzakelijk verband. Experimentele studies zijn nodig om een oorzaak-
gevolg relatie tussen slaaptekort en gezondheidsproblemen te kunnen bepalen. 
Om deze reden hebben wij in dit proefschrift in detail onderzocht wat het effect is 
van chronisch slaaptekort op de metabole regulatie in ratten. 
 Om ratten op een gecontroleerde manier bloot te stellen aan chronische 
slaaprestrictie werden ze 8 dagen gehuisvest in langzaam draaiende wielen voor 
20 uur per dag. De dieren mochten de eerste 4 uur van hun normale rustfase slapen, 
hetgeen niet voldoende was om te herstellen van de opgedane slaapschuld. Wij 
hebben hetzelfde schema aangehouden om chronisch slaaptekort te induceren 
en de metabole gevolgen te bestuderen. Om het slaaptekort te quantificeren 
werden de dieren in hoofdstuk 2 voorzien van electrodes voor het meten van 
hersenaktiviteit en het vaststellen van de slaap-waak patronen. De methode 
bleek zeer efficient in het verminderen van slaap tijdens de 20 uur per dag, wat 
leidde tot een toename in slaaptijd tijdens de 4 uur slaapmogelijkheid per dag 
en tijdens de 24 uur herstelperiode na 8 dagen met verminderde slaap. Tevens 
werd geconstateerd dat 8 dagen met verminderde slaap leidde tot een afname in 
lichaamsgewicht in vergelijking met controle dieren die onbeperkt konden slapen. 
De verklaring voor deze afname in lichaamsgewicht bleek een duidelijke toename 
in energie uitgave tijdens de periode van slaaprestrictie, vastgesteld met behulp 
van de dubbel gelabeld water methode.
 In een volgende studie werd op dag 1 en dag 8 van het slaaprestrictie protocol 
een intraveneuze glucosetolerantietest (IVGTT) uitgevoerd om de invloed van 
acuut en chronisch slaaptekort op de glucoseregulatie te bepalen (hoofdstuk 3). 
Tijdens deze test kregen de ratten een glucose-infuus en werden veranderingen 
in glucosewaarden en de insulinerespons gemeten. Ondanks dat de basale 
bloedglucose en plasma-insulinewaarden verlaagd waren was een toename 
in glucose zichtbaar tijdens de IVGTT, zowel op dag 1 als op dag 8 van het 
slaaprestrictie-protocol. Een tweede groep ratten onderging slaapverstoring 
in plaats van slaaptekort. Slaapverstoring werd geinduceerd door middel van 
meerdere kortdurende periodes geforceerde activiteit afgewisseld met periodes 
waarin de ratten vrij mochten slapen. Ondanks dit protocol hadden de ratten 
genoeg tijd per dag om te slapen (14 uur). Deze slaapverstoorde ratten lieten 
ook een hyperglycemie zien. Daarentegen was de insulinerespons tijdens de 
IVGTT juist verlaagd voor zowel ratten die blootgesteld waren aan slaaptekort als 
aan slaapverstoring. Hieruit concludeerden wij dat de glucosetolerantie van het 
lichaam verlaagd is na zowel acute als chronische slaapverstoring.
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Om te bepalen of de resultaten die we zien echt een gevolg waren van slaaptekort 
werden 2 controle experimenten uitgevoerd. In onze experimenten maakten wij 
gebruik van langzaam draaiende wielen om slaaprestrictie te induceren, wat 
inhoudt dat de ratten geforceerd werden om actief te zijn. In hoofdstuk 4 hebben 
we laten zien dat als ratten gedwongen werden om te lopen in een loopwiel, 
zonder slaaptekort te induceren, dit geen invloed had op de glucose homeostase. 
De veranderingen in glucoseregulatie in de dieren die blootgesteld werden aan 
slaaprestrictie lijken dus niet het gevolg te zijn van gedwongen activiteit. 
 Het slaaprestrictie model kan mogelijk ook een verstoring van de slaap-waak 
ritmiek teweeg brengen. Verstoring van de ritmiek kan een alternatieve verklaring 
zijn voor de veranderingen die wij zien op het metabolisme. Het is mogelijk 
dat het moment van de dag waarop de geforceerde activiteit plaatsvindt van 
belang is in het induceren van de metabole verandering. Om deze reden werd in 
hoofdstuk 5 een model voor ploegendienst opgezet om te meten wat de effecten 
van een veranderd dag-nacht ritme zijn op het metabolisme in vergelijking tot het 
slaaprestrictie model. De dieren in dit ploegendienst model hadden genoeg tijd 
om te slapen, maar de slaapfase en waakfase werden omgedraaid. Deze ratten 
werden geforceerd tot activiteit met behulp van de langzaam draaiende wielen 
voor 8 uur per dag tijdens de lichtfase, wat normaal hun slaapfase is. Een controle 
groep ratten werd geforceerd tot 8 uur activiteit tijdens de donkerfase, wat normaal 
ook de actieve fase is. Een duidelijk effect van ploegendienst op voedselinname 
was zichtbaar. De voedselinname verschoof geleidelijk naar de lichtfase waarin 
ze nu actief moesten zijn. Echter, de totale voedselinname per dag was niet 
veranderd. Aan het einde van het protocol, na 14 dagen ploegendienst, hebben 
we een IVGTT uitgevoerd om het effect van ploegendienst op de glucoseregulatie 
te bepalen. Er waren geen veranderingen zichtbaar in de respons op een IVGTT 
in vergelijking met controle ratten. We kunnen dus concluderen dat een verstoring 
in dag-nacht ritme niet leidt tot glucose intolerantie zoals zichtbaar was tijdens 
slaaprestrictie en slaapverstoring (hoofdstuk 3). 
 In al onze experimenten laten we zien dat ratten afvallen tijdens slaaptekort. 
Dit lijkt niet in overeenstemming te zijn met epidemiologische studies die 
suggereren dat slaaptekort kan leiden tot overgewicht. Een belangrijk verschil 
is dat slaaprestrictie in rattenexperimenten vaak ononderbroken zijn terwijl in 
de humane situatie het vaak een afwisseling is van periodes met slaaptekort 
(doordeweeks) en periodes van bijslapen (weekends). Het kan zijn dat deze 
continue afwisseling van slaaptekort en periodes van rust juist cruciaal zijn in 
de ontwikkeling van overgewicht. Om die reden hebben wij ratten op hetzelfde 
“week-weekend” protocol gezet. Dit houdt in dat ratten blootgesteld werden 
aan verminderde slaap voor 5 dagen per week, en vrij mochten slapen in de 
overige 2 dagen van de week. Dit protocol hebben we 4 weken aangehouden 
(hoofdstuk 6). Onze hypothese was dat dit “week-weekend” protocol de afname 
in lichaamsgewicht zou voorkomen, aangezien ratten nu tussendoor tijd hadden 
om te herstellen. Tijdens de eerste week van het protocol was een verlaging in 
lichaamsgewicht en geen verandering in voedselopname zichtbaar, vergelijkbaar 
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met de data in hoofdstuk 2 en 3. Echter, na het eerste weekend, waarin de ratten 
vrij mochten slapen, was er een extreme toename in voedselinname zichtbaar 
tijdens de slaaprestrictie dagen. Deze verhoging in voedselinname zorgde ervoor 
dat er geen verlaging in lichaamsgewicht meer plaats vond. Om precies te zijn, 
slaaprestrictie ratten bleven parallel lopen aan de controle dieren. Schijnbaar 
zorgde het weekend rust ervoor dat de dieren zich beter konden aanpassen aan 
het slaaprestrictie protocol, waardoor de voedselinname verhoogd werd en de 
ratten op deze manier konden voorkomen dat ze nog meer zouden afvallen. 
 Een ander verschil tussen ratten experimenten en de humane situatie is 
het verschil in dieet. In het dagelijkse leven hebben mensen de keuze uit vele 
types eten met verschillende hoeveelheden vet. In tegenstelling tot vet voedsel 
krijgen ratten vaak automatisch een standaard type voer (chow) met een 
laag vetgehalte. Wij wilden onderzoeken of de effecten van slaaptekort op 
lichaamsgewicht, voedselinname en regulerende hormonen leptine en insuline 
beinvloed zou worden door een medium vet dieet in vergelijking met standaard 
chow dieet (hoofdstuk 7). Voedselinname was niet verschillend tussen de ratten 
op de verschillende diëten, maar tijdens slaaptekort was het lichaamsgewicht 
van de ratten op een medium vet dieet minder extreem gedaald vergeleken met 
ratten op een chow dieet. Deze minder extreme daling in lichaamsgewicht kan ook 
een beschermende invloed hebben op de neurobiologische gevolgen van 
slaaptekort die eerder in ons lab zijn geconstateerd. Om die reden hebben 
wij onderzocht of een verschil in dieet tijdens slaaptekort invloed heeft op de 
gevoeligheid van de serotonine 1A receptor. De afname in gevoeligheid van de 
serotonine 1A receptor tijdens slaaptekort, zoals die in eerder onderzoek was 
vastgesteld, bleef bestaan, ook bij dieren op een medium vet dieet. De minder 
extreme afname in lichaamsgewicht van ratten op een medium vet dieet tijdens 
slaaptekort had dus geen effect op de serotonine 1A receptor gevoeligheid. 
Hieruit kunnen we concluderen dat de veranderingen in serotonine 1A receptor 
gevoeligheid tijdens slaaptekort niet het gevolg zijn van veranderingen in dieet 
of lichaamsgewicht, maar waarschijnlijk het gevolg zijn van een direct effect van 




In dit proefschrift hebben we onderzoek gedaan naar de invloed van slaaptekort op 
metabole processen in de rat. Onze data laten zien dat chronische slaapverstoring 
in de rat leidt tot veranderingen in de energiebalans (energie-inname en energie-
uitgave) en glucoseregulatie wat op de lange termijn zou kunnen leiden tot de 
ontwikkeling van type 2 diabetes en obesitas. Het is belangrijk om te onderzoeken 
wat de onderliggende mechanismen zijn van de metabole gevolgen van 
slaapverstoringen, in zowel de hersenen als in de periferie. De neuropeptide 
orexine zou hierin een belangrijke rol kunnen spelen. Het is bekend dat orexine 
betrokken is bij een aantal metabole processen zoals glucoseregulatie en de 
energie balans. Het is echter nog niet geheel duidelijk wat de precieze functie 
van orexine is in deze processen. Als dit eenmaal opgehelderd is, zou orexine 





Het is zover! Het is klaar! Het is wonderbaarlijk hoe snel de tijd daadwerkelijk 
gaat! Na de geweldige 8-punts cursus in 2004 bij Dierfysiologie ben ik nooit meer 
weg gegaan! Ik wil dan ook beginnen met iedereen binnen CBN te bedanken voor 
de brede interesses, de wetenschappelijke input en natuurlijk de gezelligheid. Er 
stond altijd wel iemand voor me klaar als ik vragen had over het werk, maar ook 
om een geintje mee uit te halen. Ik kon altijd heerlijk mijn energie kwijt en dat zal 
ik nooit vergeten! Bedankt!
Natuurlijk wil ik beginnen met jou te bedanken, Anton, mijn promotor. Ik weet 
nog als de dag van gisteren dat ik bij jou kwam om te lobbyen voor een PhD 
positie, dat jij even weg liep en 10 min later weer terug kwam met de mededeling 
dat je wel een baan voor me had. Ik heb veel van jou geleerd in de afgelopen 
4 jaar. Jouw nuchtere en Tukkerse manier van doen heeft mij in veel situaties 
ontzettend geholpen; je stond altijd voor me klaar als ik dat nodig had en dat was 
een fijn gevoel! Ik weet dat je einddoel was dat ik speciaal en luxe eten zou gaan 
waarderen… Tja, het enige wat ik kan zeggen is; ik zal blijven oefenen in Seattle!
 Beste Peter, mijn co-promotor. Dankzij Anton kregen we de kans om onze 
samenwerking voort te zetten in dit PhD-project. We hebben zoveel meegemaakt 
in de afgelopen jaren dat ik het dan ook lastig vind om onder woorden te brengen 
waarvoor ik je allemaal wil bedanken. Onze wetenschappelijke discussies waren 
informatief, maar ook altijd erg gezellig (met koffie en/of chocola) en ik kon dan 
ook altijd bij je terecht met praktische problemen en vragen. Buiten dat om ben 
ik jou dankbaar voor de introductie in het “slaap-wereldje”. In Australië heb je me 
aan veel personen voorgesteld, waar ik nu in mijn nieuwe baan in Seattle nog 
altijd profijt van heb. Ik hoop dan ook dat we contact houden en af en toe kunnen 
bijkletsen (en whisky drinken) op de altijd gezellige slaap-bijeenkomsten!
 Verder wil ik de leescommissie bedanken voor het kritisch lezen van mijn 
proefschrift. Beste Domien en Dries, heel erg bedankt voor de tijd die jullie nu in 
mijn proefschrift hebben gestoken en natuurlijk ook voor de input in de afgelopen 
jaren tijdens groepsbesprekingen en congressen. Dear Kim, first of all thank you 
for carefully reading my thesis and for giving important feedback. I also want to 
thank you for your help with the writing and all other social aspects especially after 
work. Thanks for everything. 
 Dear Mark, already 2 years ago you asked me if I was interested in a postdoc 
position in the States. Thanks for keeping in contact through those years and 
offering me this position in Seattle. I am looking forward to working with you in the 
upcoming years.
Dan mijn paranimfjes! Lieve Marco, wat ben ik blij dat jij mijn paranimf wilt zijn! 
Het is wonderbaarlijk hoe wij op dezelfde manier denken en reageren. Jij snapt 
altijd hoe ik me voel (in welke situatie dan ook) en jouw steun is dan ook erg 
belangrijk voor me (geweest). Jij bent tenslotte de enige die mijn foute muziek 
smaak echt kan waarderen (Gasolinaaaa). Ik ga je ontzettend missen! Simon, mijn 
paranimf en kamergenoot die het al het langst met mij vol houdt! Onze kantoor-
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gesprekken heb ik altijd erg leuk gevonden. Of het nou ging over de details van 
een experiment, over wetenschap in het algemeen, over de toekomst of over 
buiten-werk-activiteiten; jij wist er altijd een komische draai aan te geven. Of dit 
nou ligt aan het feit dat jij ook Tukker bent weet ik niet, maar gezellig was het altijd. 
Dit heeft ook zeker geholpen in de “zware” zomer van 2010 waarin alles tegenzat. 
Heel erg bedankt dat jij mijn paranimf wilt zijn! 
Wetenschap is iets wat je samen doet en waarbij sociale interacties echt belangrijk 
zijn. Ik wil dan ook al mijn kamergenootjes door de tijd heen bedanken. Marcelo, 
although we only shared an office for a few months at the BC, we have always 
been close and good friends. You were always there for me; this meant a lot to me 
and it still does. Gretha, mijn grote voorbeeld! Vanaf het moment dat ik begon aan 
dit project ben jij er geweest om zowel praktisch als theoretisch te helpen. Jij hebt 
me veel technieken geleerd en zonder jou was het een stuk zwaarder geweest. 
Ik zal onze congresmomenten ook niet snel vergeten, vooral onze nachtelijke 
acties blijven spectaculair. Als jij sliep, begon ik te praten en te wandelen en als 
ik eindelijk rustig was en even mijn ogen open deed, keek ik recht in jouw (geheel 
wakkere en heldere) ogen en dan wist ik dat het alweer 6 uur was! Heel erg 
bedankt voor alles! Caroline (CC), jouw extreem nuchtere en zakelijke manier van 
denken was vaak zeer verhelderend. Super leuk om te zien hoe duidelijk je kunt 
zijn naar anderen; of dit nou gaat om mede AIOs of onze bazen, het maakt jou niet 
uit. Ondanks dat we vaak even moed moesten verzamelen om te gaan sporten, 
hebben we toch altijd doorgezet en was het achteraf een super gezellig sportuurtje 
(of kletsuurtje?). Heel erg bedankt hiervoor! (Klaar nu! Doeg!) Dear Stefano and 
Federica, it was a pleasure to share an office with you in the new building. Thanks 
for the ‘gezelligheid’! Grazie! Jan en Fiona, ik ken jullie beide al erg lang. Eerst als 
studenten en erna als mede AIOs. Ik kan me geen betere nieuwe AIO’s voorstellen 
in onze groep, zowel qua werk, maar ook qua gekheid. Iemand moet mijn rol toch 
een beetje gaan overnemen en ik weet zeker dat ik dit aan jullie kan overlaten! 
Bedankt voor alles, vooral jullie steun in de laatste maanden. 
 Dear Arianna, although we technically shared an office in the new building, I 
probably spent more time in your office at the BC. If I needed advice, talk about 
data, or just personal stuff, you were there. I am really happy that we worked 
together on some of our projects and will not forget the moments in the basement 
during the IVGTTs/challenges. Lots of fun! Grazie! Lieve Henriette, het is 
ongelooflijk hoeveel tijd wij samen doorgebracht hebben. In onze kantoren, samen 
werken in de kelder, basketbal, Buckshot, de bioscoop of gewoon hangend op de 
fiets bij het kruispunt waar we beide een andere kant op moesten. Het laatste jaar 
zagen we elkaar al minder, maar we hebben altijd mailcontact gehouden en het is 
mijn doel om dit ook zeker voort te zetten. We moeten elkaar toch een beetje op 
de hoogte blijven houden! En anders moet je maar zo denken; we hebben altijd 
Marco Borsato nog!
 Binnen Neuroendocrinologie wil ik ten eerste Jan Strubbe bedanken voor de 
input tijdens besprekingen en de grote hoeveelheid literatuur die altijd beschikbaar 
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(en geordend) was. Ik ben erg blij dat ik nog gebruik heb kunnen maken van jouw 
kennis in de afgelopen jaren! Ten tweede wil ik Gertjan bedanken. Ik ben erg blij 
dat we in mijn laatste jaar nog echt hebben kunnen samenwerken en gelukkig zijn 
de data die daaruit voort kwamen ook nog eens super mooi. Buiten dat om wil ik je 
ook bedanken voor het feit dat jij zag als er mij iets dwars zat en dat ik dan altijd 
mijn verhaal bij jou kwijt kon als ik die behoefte had. 
 Verder wil ik iedereen binnen de groep Gedragsfysiologie bedanken. Jaap, 
Sietse en Bauke, ontzettend bedankt voor alle wetenschappelijke input en buiten 
dat om ook voor jullie geintjes tijdens de pauzes, feestjes en groepsuitjes. Dit 
zorgde ervoor dat ik me altijd zeer goed vermaakte en me helemaal thuis voelde. 
 Beste Eddy, Menno en Roelof. Tijdens mijn eerste masterproject heb ik veel 
met jullie samengewerkt en heb toen ontdekt dat wetenschap te leuk is om niet in 
verder te gaan. Ik ben erg blij dat uit dat werk een mooie publicatie voortgekomen 
is. Verder vond ik de deelname aan jullie groepsbesprekingen erg leerzaam, door 
de input vanuit allerlei wetenschappelijke hoeken. Dank jullie wel. 
 Natuurlijk zijn er nog vele andere collega’s tegen wie ik een persoonlijk woord 
wil zeggen. Henk, kanjer! Ik mag dan één van jouw kanjers zijn; jij bent een 
kanjer voor mij. Jij maakte de geld- en andere zakelijke kanten van deze baan 
een stuk simpeler en leuker. Geweldig dat je mij altijd steunde om iemand er 
tussen te nemen, dat je mij vaak als eerste meldde dat je me miste als ik op 
congres of vakantie was en dat je zo heerlijk enthousiast was rondom groepsuitjes 
en dergelijke. Ontzettend bedankt voor de steun, de gezelligheid en de geintjes! 
Jan B, mijn operatiemaatje. Jij hebt mij op een heel gezellige manier de jugularis 
cannulatie geleerd. Ik geniet nog steeds van het feit dat ik die ene keer sneller 
was dan jij; al die andere keren vergeten we gewoon. Ondanks dat ik het er niet 
mee eens ben dat jij vaker op Ameland komt dan ik, hoop ik dat je mijn eilandje 
de komende jaren een beetje voor me in de gaten wilt houden! Heel erg bedankt 
voor alles! Wanda, ontzettend bedankt dat jij de orexine metingen voor me wilde 
uitvoeren. Verder natuurlijk ook bedankt voor je hulp en enthousiasme bij de 
organisatie van sinterklaasavonden. Pleunie, Marlies en Joke, heel erg bedankt 
voor jullie hulp bij de kleine, maar toch zeker niet onbelangrijke dingen waar we 
allemaal mee te maken krijgen. Organisatie en planning van uitjes, alles rondom 
de verhuizing naar het CvL, en gewoon de gezelligheid tijdens de pauzes. Verder 
wil ik de volgende personen bedanken voor hulp in de kelder of in het lab, voor de 
gezelligheid en de goede sfeer: Linda, Auke, Jaap B, Martijn S, Christa, Rick en 
Jan K. Bedankt voor alles! 
 Veel van het praktische werk had ik niet kunnen doen zonder hulp van mijn 
masterstudenten: Daan Middendorp, Maurien Pruis, Jantien Zandvoort, Vincenzo 
Terlizzo en Tifany Desprez. Thanks guys for helping me out practically, but also for 
making the experiments more fun.  
Buiten het werk om wil ik een aantal vrienden ontzettend bedanken voor hun 
luisterend oor en het zorgen voor afleiding. Gonda en Marije, wat hebben we veel 
meegemaakt tijdens de BCN master. Wij zijn de start geweest van de B-track, 
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waar we zonder (de helaas veel te vroeg overleden) Henk Visser waarschijnlijk 
niet aan begonnen waren. Ik vind het dan ook erg jammer dat Henk dit niet heeft 
mogen meemaken. Ik ben zeer blij dat wij na al die jaren nog altijd goed contact 
hebben en af en toe lekker bijkletsen. Karin, ik vind het super dat wij na het VWO 
altijd contact zijn blijven houden. Via msn hebben we elkaar de grootste verhalen 
verteld en ik kon altijd mijn verhaal bij jou kwijt, onafhankelijk van het onderwerp. 
Onze super vakantie naar Egypte zal ik dan ook niet snel vergeten! Bedankt voor 
alles! Esther, heel erg bedankt voor alle gezellige momenten in de afgelopen 
jaren. Altijd fijn als iemand net zo’n film- en cabaret-freak is als ikzelf! Ik ben dan 
ook erg blij dat je een aantal jaren geleden besloot in Groningen te gaan studeren 
zodat we nog vaker naar het theater en de bioscoop konden! Dit ga ik erg missen, 
maar ik weet ook zeker dat we (net als vroeger) gewoon weer ellenlange mailtjes 
gaan sturen om elkaar op de hoogte te houden van… alles!
 Natuurlijk moet ik mijn roomies/ceramchickies uitgebreid bedanken! Aan het 
begin van deze 4 jaar was ik van plan om een appartementje te zoeken, maar 
door de gezelligheid met jullie ben ik de hele 4 jaar blijven hangen! Carola, Yteke 
en Emma, zonder jullie was het totaal anders geweest en misschien gewoonweg 
niet te doen. We konden altijd onze verhalen bij elkaar kwijt, advies aan elkaar 
vragen of gewoon lekker samen op de kamer hangen. Het is nu al heel raar om 
jullie niet meer dagelijks om me heen te hebben. Ik weet zeker dat we contact 
zullen houden en ben zeer benieuwd waar wij allemaal staan over 10 jaar! Heel 
erg bedankt chicks!
Last but not least; pap en mam! Ik hoef jullie niet uit te leggen hoe belangrijk 
jullie voor mij zijn en hoe fijn ik het vind dat jullie mij altijd steunden en steunen 
in alles wat ik deed en doe. Het maakt niet uit of het nou gaat om werk, vakantie, 
gevaarlijke sporten of zelfs verhuizen naar de andere kant van de wereld! Ik ben 
super trots op alles wat jullie doen en weet ook dat jullie net zo trots op mij zijn! 
Ik ga jullie, opa en oma en natuurlijk alle kids ontzettend missen (op wie moet ik 
nu mijn energie kwijt als ik Karin niet elk weekend kan pesten?). Gelukkig is het 
tegenwoordig steeds gemakkelijker om contact te houden en vliegen de komende 
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